Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3035999	li-laktaat	mmol/l (mmol/l)	2903	3517	0.28%
3035999	li-laktaat	— (—)	280	301	100.00%	Distribution not available
3035999	li-laktteh	mmol/l (mmol/l)	192	296	0.00%
3035999	li-laktteh	— (—)	45	65	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Epilepsy

480

671

7.32

323.31

1.5

1.3

2.21

2.06

mmol/l

1.33

449

628

Inflammatory diseases of the central nervous system

280

199

15.25

311.02

1.9

1.2

3.07

1.93

mmol/l

8.68

271

189

General symptoms and signs

1134

1357

4.24

307.65

1.3

1.2

2.01

2.08

mmol/l

0.73

1056

1264

Other degenerative diseases of the nervous system

368

204

14.01

307.65

1.1

1.79

2.06

mmol/l

3.36

341

186

Symptoms and signs involving the nervous and musculoskeletal systems

773

1528

5.16

307.65

1.3

1.89

2.16

mmol/l

6.85

723

1417

Headache

936

1195

6.68

307.65

1.3

1.2

1.89

2.04

mmol/l

3.17

863

1113

Neurological diseases

955

712

6.84

307.65

1.3

1.2

1.89

2.09

mmol/l

2.58

894

661

Other neurological diseases

821

1512

4.44

302.88

1.5

1.2

2.08

2.16

mmol/l

0.92

762

1393

Other symptoms and signs involving cognitive functions and awareness

544

873

5.97

294.97

1.2

1.3

2.08

2.21

mmol/l

1.22

509

802

Hydrocephalus

238

137

18.80

294.93

2.3

1.2

2.34

2.03

mmol/l

2.35

226

125

Symptoms and signs involving cognition, perception, emotional state and behaviour

1017

1962

3.68

280.42

1.2

1.3

1.99

2.12

mmol/l

2.11

945

1819

Other symptoms and signs involving the nervous and musculoskeletal systems

557

1114

5.11

260.84

1.3

1.88

2.09

mmol/l

3.81

527

1036

Neurological diseases, wide definition

382

149

13.06

256.46

1.4

1.2

1.86

1.84

mmol/l

0.09

359

140

Convulsions, not elsewhere classified

337

415

8.21

250.14

1.4

1.3

2.09

1.94

mmol/l

1.14

306

393

Fever of other and unknown origin

520

1017

4.80

222.49

1.3

1.2

2.14

2.05

mmol/l

0.61

484

947

Demyelinating diseases of the central nervous system

237

223

11.30

220.60

1.1

1.4

1.68

2.00

mmol/l

3.81

222

205

Intracranial trauma

430

534

6.07

217.87

1.4

1.1

2.09

1.98

mmol/l

0.67

388

496

Focal epilepsy

347

528

6.78

217.25

1.4

1.2

2.20

2.00

mmol/l

1.93

321

490

Focal epilepsy, strict definition

327

485

6.96

209.87

1.5

1.2

2.17

2.01

mmol/l

1.46

303

450

Episodal and paroxysmal disorders

1026

1686

3.15

201.68

1.3

1.2

1.93

2.10

mmol/l

3.52

955

1562

Concussion

365

513

6.22

201.45

1.3

1.1

2.05

1.99

mmol/l

0.27

329

475

Viral infections of the central nervous system

203

180

12.03

196.75

1.5

1.3

2.20

1.97

mmol/l

2.15

192

169

Abnormal findings on diagnostic imaging of central nervous system

163

100

17.91

196.18

1.3

1.5

1.89

1.92

mmol/l

0.08

150

Cerebrovascular diseases (FINNGEN)

436

593

5.37

190.54

1.6

1.1

2.25

1.91

mmol/l

5.66

401

557

Focal epilepsy, mode (most common among epilepsy diagnosis)

306

470

6.72

190.02

1.5

1.2

2.23

2.01

mmol/l

1.73

284

436

MS-disease / Multiple Sclerosis

192

172

11.84

184.67

1.1

1.4

1.67

1.89

mmol/l

3.95

177

160

Cerebrovascular diseases

679

1364

3.61

184.06

1.5

1.2

2.28

2.14

mmol/l

1.51

624

1266

Condition for Implicit Sepsis (Organ dysfunction codes)

770

1759

3.21

175.98

1.2

1.3

2.11

2.07

mmol/l

0.28

716

1634

Meningitis

158

114

15.00

173.99

2.1

1.2

3.51

1.92

mmol/l

6.50

153

108

Malaise and fatigue

423

780

4.57

164.95

1.3

1.2

2.01

2.13

mmol/l

1.00

388

725

Implicit Sepsis

667

1581

3.32

163.48

1.3

2.14

2.06

mmol/l

0.64

619

1462

STROKE

578

1104

3.68

159.26

1.5

1.2

2.24

2.04

mmol/l

2.84

531

1032

Stroke, including SAH

563

1156

3.65

156.72

1.5

1.2

2.35

2.18

mmol/l

1.71

514

1069

Migraine

476

1086

3.77

145.31

1.2

1.3

1.81

1.97

mmol/l

2.92

445

1011

Visual disturbances and blindness

500

1446

3.51

142.99

1.3

1.94

2.08

mmol/l

1.81

448

1354

Spirochaetal infections, other/unspecified

169

188

9.44

139.14

1.2

1.4

1.89

2.11

mmol/l

1.46

154

177

Other demyelinating diseases of the central nervous system

123

15.17

136.19

1.2

1.5

1.70

1.91

mmol/l

1.91

117

Postprocedural disorders of nervous system

155

168

9.66

130.08

1.3

1.2

1.72

2.02

mmol/l

1.55

144

157

Visual disturbances

461

1348

3.47

129.69

1.3

1.90

2.08

mmol/l

2.94

416

1265

Bacterial infection, other or unspecified

460

1219

3.45

124.89

1.3

2.37

2.07

mmol/l

2.97

427

1124

Dizziness and giddiness

584

1586

3.02

124.42

1.3

1.94

2.14

mmol/l

3.26

541

1468

Cerebral cysts

128

113

11.95

124.23

1.3

1.2

1.77

1.97

mmol/l

1.59

120

104

Stroke, excluding SAH

487

1104

3.31

117.89

1.5

1.2

2.27

2.19

mmol/l

0.45

446

1018

Implicit bacterial Sepsis

344

794

4.03

117.53

1.3

2.33

2.11

mmol/l

1.39

312

734

Abnormalities of gait and mobility

169

234

7.46

115.74

1.4

1.2

1.89

2.09

mmol/l

1.64

155

221

Infections, IBD-co-morbidities

142

11.53

114.65

1.3

1.2

2.20

1.91

mmol/l

1.43

133

Other and unspecified hydrocephalus

30.52

113.25

2.8

1.2

2.13

1.88

mmol/l

0.96

Certain infectious and parasitic diseases

779

1497

2.62

111.87

1.3

1.2

2.05

1.96

mmol/l

1.22

739

1379

Other headache syndromes

365

1017

3.63

110.53

1.2

1.3

1.84

2.05

mmol/l

4.66

342

948

Bacterial Sepsis

370

920

3.62

108.02

1.3

2.42

2.08

mmol/l

2.45

336

853

Implicit viral Sepsis

217

416

5.33

107.03

1.3

1.2

2.34

2.00

mmol/l

1.51

202

386

Viral Sepsis

217

416

5.33

107.03

1.3

1.2

2.34

2.00

mmol/l

1.51

202

386

Polyneuropathies and other disorders of the peripheral nervous system

241

519

4.74

103.79

1.2

1.3

2.01

2.12

mmol/l

0.98

226

490

Delirium, not induced by alcohol and other psychoactive substances

143

185

7.94

103.64

1.3

1.2

2.10

2.07

mmol/l

0.15

133

169

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

274

268

5.16

98.93

1.4

1.2

2.00

2.17

mmol/l

0.59

259

245

Disorders of optic nerve and visual pathways

156

249

6.48

93.67

1.3

1.73

1.98

mmol/l

2.56

141

234

Speech disturbances, not elsewhere classified

136

188

7.50

93.41

1.4

1.2

2.14

2.02

mmol/l

0.49

127

175

Ischaemic Stroke, excluding all haemorrhages

424

1053

3.07

91.66

1.3

2.18

2.22

mmol/l

0.26

396

972

Disturbances of skin sensation

298

825

3.67

91.46

1.2

1.3

1.70

2.00

mmol/l

10.13

276

768

Other bacterial diseases

700

2060

2.37

89.58

1.3

2.38

2.01

mmol/l

5.33

653

1906

Sequelae of cerebrovascular disease

275

627

3.90

88.95

1.6

1.2

2.24

2.22

mmol/l

0.09

254

583

Anaemias

223

300

5.00

88.59

1.2

1.1

2.07

1.72

mmol/l

4.18

207

285

Nontraumatic intracranial haemmorrhage

190

385

5.02

87.91

2.1

1.2

2.79

2.12

mmol/l

5.26

167

360

Pain, not elsewhere classified

212

484

4.43

84.72

1.3

1.90

1.99

mmol/l

0.63

187

458

Autoimmune diseases excluding thyroid diseases

795

1984

2.24

84.65

1.2

1.3

2.01

2.08

mmol/l

0.62

747

1839

Autoimmune diseases excluding thyroid diseases, strict definition

770

1925

2.24

82.52

1.2

1.3

2.01

2.08

mmol/l

0.63

724

1780

Aneurysms, operations, SAH

176

355

5.06

82.03

2.1

1.2

2.65

2.12

mmol/l

3.85

160

334

Anxiety disorders, excluding more controls

617

1708

2.41

81.54

1.2

1.99

2.06

mmol/l

0.58

567

1596

Other antidepressants

771

1809

2.24

80.65

1.2

2.03

2.11

mmol/l

0.74

720

1676

Medical observation and evaluation for suspected diseases and conditions

519

986

2.71

80.26

1.3

1.2

1.96

2.11

mmol/l

1.54

482

919

Autoimmune diseases related-to ILD

649

2531

2.27

79.97

1.2

1.3

1.95

2.09

mmol/l

2.13

600

2345

Other and unspecified polyneuropathies, also in other diseases

199

455

4.46

79.65

1.2

1.3

2.00

2.13

mmol/l

1.12

186

428

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

111

9.24

79.60

1.8

1.2

2.46

2.01

mmol/l

1.89

105

Organic, including symptomatic, mental disorders

357

825

3.16

79.58

1.2

1.3

2.05

2.27

mmol/l

2.54

328

761

Hypo-osmolality and hyponatraemia

168

334

5.11

79.22

1.5

1.3

2.46

2.11

mmol/l

0.97

157

312

Syncope and collapse

287

749

3.42

77.39

1.2

2.07

2.12

mmol/l

0.17

265

695

Mood disorders, excluding more controls

679

1833

2.27

76.61

1.3

1.2

2.04

2.09

mmol/l

0.38

626

1712

General examination and investigation of persons without complaint and reported diagnosis

492

985

2.68

75.17

1.3

1.2

2.05

2.11

mmol/l

0.46

463

918

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

111

156

7.36

75.13

1.8

1.2

2.50

2.10

mmol/l

1.40

104

147

Subarachnoid haemorrhage

127

206

6.32

74.94

2.5

1.3

2.90

2.15

mmol/l

4.22

113

193

Other disorders of fluid, electrolyte and acid-base balance

249

670

3.63

74.78

1.4

1.3

2.41

2.14

mmol/l

1.13

233

624

Persons encountering health services in other circumstances

328

1111

2.98

72.33

1.3

2.04

1.99

mmol/l

0.28

307

1027

Psychiatric diseases

767

1803

2.14

71.61

1.3

1.2

2.08

mmol/l

0.02

705

1681

Disorders of thyroid, IBD co-morbidities

108

8.19

69.91

1.5

1.2

2.15

1.87

mmol/l

1.45

101

Dorsalgia

736

1881

2.13

69.41

1.3

1.94

2.12

mmol/l

3.29

680

1748

Anxiety disorders

670

2221

2.15

69.24

1.2

1.3

1.96

2.04

mmol/l

0.83

616

2070

Migraine without aura

186

451

4.18

68.88

1.2

1.3

1.71

1.90

mmol/l

3.05

173

428

Malignant neoplasm of eye, brain and central nervous system

9.65

68.84

1.9

1.3

2.43

1.92

mmol/l

2.84

Neurotic, stress-related and somatoform disorders

662

2201

2.15

68.48

1.2

1.3

1.95

2.05

mmol/l

1.03

610

2049

Nausea and vomiting

235

667

3.51

67.46

1.3

2.10

2.01

mmol/l

0.51

221

618

Migraine with aura

204

543

3.80

66.35

1.2

1.3

1.77

1.96

mmol/l

2.82

190

515

Diplopia

149

314

4.85

66.10

1.2

1.3

1.88

2.11

mmol/l

2.12

136

298

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

448

1712

2.44

66.00

1.3

2.05

2.17

mmol/l

1.30

419

1581

ILD medications

814

2239

2.01

65.91

1.2

1.3

2.06

2.04

mmol/l

0.08

750

2080

Low back pain

532

1803

2.29

64.99

1.2

1.3

1.93

2.13

mmol/l

3.83

491

1675

Opioids

725

1828

2.09

64.90

1.2

1.3

2.02

2.05

mmol/l

0.20

671

1702

Symptoms and signs involving the skin and subcutaneous tissue

499

2177

2.30

64.89

1.2

1.3

1.84

2.13

mmol/l

10.59

466

2019

Lyme disease

234

695

3.42

64.65

1.2

1.4

1.91

2.12

mmol/l

3.41

212

653

Other soft tissue disorders, not elsewhere classified

678

1997

2.11

64.59

1.2

1.3

1.95

2.10

mmol/l

2.59

627

1854

Complications of medical and surgical care

512

2155

2.27

64.25

1.6

1.2

2.17

2.09

mmol/l

0.67

481

1992

Other spirochaetal diseases

235

704

3.39

64.05

1.2

1.4

1.91

2.13

mmol/l

3.45

213

662

620

1796

2.18

64.04

1.3

1.2

2.29

2.01

mmol/l

4.45

572

1670

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

620

1796

2.18

64.04

1.3

1.2

2.29

2.01

mmol/l

4.45

572

1670

Myalgia

219

633

3.51

63.11

1.2

1.4

1.87

2.04

mmol/l

1.62

202

592

Nerve, nerve root and plexus disorders

734

2292

2.02

62.92

1.2

1.3

2.04

2.12

mmol/l

0.89

684

2121

Mood [affective] disorders

730

2392

2.02

62.89

1.3

2.02

2.08

mmol/l

0.57

669

2222

Parasetamol

583

1320

2.27

62.69

1.2

1.97

2.00

mmol/l

0.17

542

1228

Used for control exclusion in common control thyroid runs

740

1837

2.05

62.38

1.2

1.3

1.95

2.08

mmol/l

2.04

684

1702

Depression medications

251

345

3.69

62.19

1.3

1.1

1.89

1.71

mmol/l

1.83

231

326

Mood disorders

729

2394

2.01

62.17

1.2

1.3

2.01

2.08

mmol/l

0.70

669

2224

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

672

2363

2.05

61.55

1.3

2.18

2.05

mmol/l

1.26

622

2198

Other dorsopathies, not elsewhere classified

727

1896

2.03

60.48

1.2

1.3

1.93

2.11

mmol/l

3.51

673

1762

Cerebral palsy and other paralytic syndromes

132

272

4.96

60.17

2.0

1.2

2.01

2.02

mmol/l

0.01

124

257

First line medication for Crohn's disease

779

2169

1.97

59.89

1.3

1.2

2.13

2.00

mmol/l

1.31

717

2014

Explicit Sepsis

291

988

2.85

58.77

1.4

1.3

2.53

2.05

mmol/l

3.52

269

915

ILD medications: prednisolone, methylprednisolone, prednisone

759

2194

1.96

58.55

1.3

2.12

2.05

mmol/l

0.48

701

2037

Influenza and pneumonia

733

2469

1.96

58.43

1.3

1.2

2.21

2.00

mmol/l

3.57

679

2295

Depression

674

2324

2.01

57.89

1.2

1.3

2.02

2.07

mmol/l

0.40

614

2161

Any mental disorder

743

1883

1.99

57.18

1.3

1.2

2.08

2.09

mmol/l

0.05

681

1757

Other disorders of optic [2nd] nerve and visual pathways

151

6.44

56.22

1.4

1.76

1.94

mmol/l

1.57

143

Other septicaemia

254

845

2.98

55.89

1.4

1.3

2.35

2.07

mmol/l

2.60

235

782

Oedema, not elsewhere classified

187

524

3.58

55.89

1.3

2.06

2.10

mmol/l

0.16

177

490

Intracranial injury

410

1704

2.34

55.53

1.4

1.2

2.01

2.06

mmol/l

0.34

370

1581

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

422

1841

2.30

55.16

1.7

1.2

2.15

2.09

mmol/l

0.40

397

1697

Pneumonia, organism unspecified

614

2199

2.03

55.04

1.3

2.23

2.02

mmol/l

3.15

569

2046

Benzodiazepine use

684

2506

1.95

54.76

1.3

1.98

2.10

mmol/l

1.95

635

2320

Autoimmune diseases

754

2000

1.93

54.28

1.2

1.3

1.99

2.08

mmol/l

1.18

700

1854

Traumatic subdural haemorrhage

7.77

53.67

1.5

1.1

2.54

2.22

mmol/l

0.68

Oral corticosteroids

728

2306

1.92

53.52

1.3

2.11

2.06

mmol/l

0.34

674

2139

ILD medications: immunosuppressive drugs

438

1887

2.24

53.48

1.2

1.3

2.12

2.06

mmol/l

0.25

410

1756

Septicaemia

274

959

2.77

52.66

1.4

1.3

2.57

2.08

mmol/l

3.24

254

886

Persons encountering health services in other circumstances, wide

805

2245

1.87

52.64

1.3

1.2

2.09

2.06

mmol/l

0.29

755

2073

Hard cardiovascular diseases

504

1501

2.17

52.07

1.4

1.2

2.23

2.16

mmol/l

0.50

463

1401

Cardiovascular diseases

477

1161

2.25

51.63

1.3

1.2

1.96

1.81

mmol/l

2.15

446

1081

Any gastric operation

575

1380

2.10

51.49

1.4

1.2

1.99

1.98

mmol/l

0.12

537

1281

GASTRO-related operations

575

1380

2.10

51.49

1.4

1.2

1.99

1.98

mmol/l

0.12

537

1281

Diseases of the eye and adnexa

591

1434

2.07

51.21

1.3

1.2

1.92

2.05

mmol/l

1.55

546

1346

Pneumonias (Asthma/COPD co-morbidities)

673

2445

1.92

50.80

1.3

1.2

2.22

2.01

mmol/l

3.46

620

2273

All pneumoniae

676

2458

1.91

50.29

1.3

1.2

2.23

2.01

mmol/l

3.58

623

2286

Bell's palsy

126

291

4.42

49.99

1.2

1.3

2.05

1.99

mmol/l

0.21

121

268

Benign neoplasm of meninges

105

209

5.14

49.91

1.5

1.2

2.52

2.10

mmol/l

1.38

198

Other anxiety disorders

353

1313

2.40

49.85

1.2

1.3

1.84

1.91

mmol/l

0.79

327

1228

Pain (limb, back, neck, head abdominally)

484

1095

2.23

49.82

1.3

1.2

1.96

2.19

mmol/l

2.88

457

1010

Complications of surgical and medical care, not elsewhere classified

645

2414

1.93

49.79

1.5

1.2

2.12

2.08

mmol/l

0.36

607

2230

COPD/asthma/ILD related infections

692

1799

1.94

49.69

1.3

1.2

2.10

2.01

mmol/l

1.01

639

1673

COPD/asthma related infections

692

1799

1.94

49.69

1.3

1.2

2.10

2.01

mmol/l

1.01

639

1673

Persons encountering health services for specific procedures and health care

726

2417

1.87

49.63

1.4

1.2

2.13

2.01

mmol/l

1.75

655

2264

Persons with potential health hazards related to communicable diseases

317

1277

2.48

49.20

1.2

1.3

1.86

1.88

mmol/l

0.22

304

1189

Metabolic disorders

610

1931

1.97

48.85

1.3

2.21

2.07

mmol/l

1.21

568

1787

Other special examinations and investigations of persons without complaint or reported diagnosis

443

986

2.29

48.62

1.3

1.2

2.04

2.11

mmol/l

0.46

412

919

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

654

2426

1.90

48.57

1.3

2.23

2.03

mmol/l

2.93

601

2256

Tramadol

518

1609

2.08

48.35

1.3

2.01

2.09

mmol/l

0.73

477

1493

Cardiovascular diseases (excluding rheumatic etc)

488

1324

2.14

47.65

1.4

1.2

2.00

1.81

mmol/l

3.20

453

1229

Parkinson's disease, excluding more controls

7.21

47.47

1.2

1.94

2.11

mmol/l

0.70

Benign neoplasm of meninges

105

219

4.90

47.29

1.5

1.3

2.52

2.11

mmol/l

1.32

204

Symptoms and signs involving speech and voice

245

897

2.76

47.11

1.3

2.09

2.06

mmol/l

0.14

231

834

Hypothyroidism (congenital or acquired)

193

322

3.47

46.49

1.2

1.1

1.89

1.71

mmol/l

2.06

179

305

Paralytic strabismus

146

5.91

46.37

1.5

1.2

1.90

2.01

mmol/l

0.55

136

Inflammatory bowel disease treatment related agents

763

2405

1.81

46.27

1.3

2.09

2.05

mmol/l

0.33

708

2231

Depression or dysthymia

432

1092

2.22

45.97

1.3

1.2

2.04

2.14

mmol/l

0.91

399

1016

Anxiety (asthma-related co-morbidities)

426

1570

2.15

45.44

1.2

1.3

1.88

1.98

mmol/l

1.08

392

1470

Symptoms and signs involving the urinary system

490

1867

2.04

45.27

1.4

1.3

2.20

2.10

mmol/l

0.68

455

1730

Abnormal involuntary movements

116

272

4.34

45.12

1.5

1.2

1.84

2.14

mmol/l

2.52

106

254

Substance abuse, excluding more controls

362

1402

2.27

45.10

1.3

2.18

2.08

mmol/l

0.62

335

1316

Bleeding

516

1880

2.01

45.03

1.6

1.2

2.38

2.08

mmol/l

4.61

463

1752

Codeine

623

1791

1.92

44.94

1.2

1.3

2.08

2.05

mmol/l

0.13

567

1668

Contact with and exposure to communicable diseases

271

1065

2.56

44.85

1.2

1.3

1.83

1.86

mmol/l

0.24

259

993

Pain in joint

361

1030

2.33

44.81

1.1

1.2

1.94

2.20

mmol/l

2.40

328

951

Dorsopathies

693

1907

1.86

44.80

1.2

1.3

1.91

2.11

mmol/l

4.60

644

1773

Parkinson's disease, strict definition, excluding more controls

7.70

44.77

1.2

1.1

1.96

2.15

mmol/l

0.63

Hypothyroidism and >3 levothyroxin purchases

189

320

3.42

44.69

1.2

1.1

1.90

1.71

mmol/l

2.18

177

303

Hypothyroidism, levothyroxine purchases

189

320

3.42

44.69

1.2

1.1

1.90

1.71

mmol/l

2.18

177

303

Lower back pain or/and sciatica

670

2543

1.84

44.48

1.2

1.3

1.92

2.11

mmol/l

5.20

617

2358

Renal tubulo-interstitial diseases

552

2195

1.94

44.10

1.4

1.2

2.23

2.04

mmol/l

2.29

509

2040

Benign neoplasm: Cerebral meninges

190

5.06

43.95

1.3

1.2

2.52

2.07

mmol/l

1.29

179

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

378

1746

2.18

43.52

1.7

1.2

2.14

2.11

mmol/l

0.22

356

1607

Other reaction to severe stress, and adjustment disorders

281

1150

2.46

43.06

1.3

2.05

1.93

mmol/l

0.69

256

1074

Injuries to the head

710

2593

1.79

42.97

1.3

1.2

2.03

2.06

mmol/l

0.27

657

2404

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

211

751

2.84

42.82

1.4

1.2

2.00

1.89

mmol/l

0.81

189

705

All anxiety disorders

431

1671

2.09

42.78

1.2

1.3

1.87

1.96

mmol/l

1.12

397

1562

Benign neoplasm: Cerebral meninges

197

4.88

42.14

1.3

2.52

2.13

mmol/l

1.02

183

Persons encountering health services for other counselling and medical advice, not elsewhere classified

703

2236

1.80

42.00

1.2

2.10

2.06

mmol/l

0.30

655

2064

Disorders of ocular muscles, binocular movement, accommodation and refraction

336

1495

2.25

41.61

1.4

1.2

1.95

1.98

mmol/l

0.28

307

1403

Migraine without aura and triptan purchases

153

461

3.37

41.53

1.2

1.3

1.69

1.93

mmol/l

3.95

142

435

Alzheimer disease, excluding more controls

6.02

41.02

1.1

1.99

2.17

mmol/l

0.72

Continuous positive airway pressure

145

359

3.52

40.73

1.2

2.12

1.92

mmol/l

1.26

136

343

Strabismus

217

817

2.68

39.49

1.4

1.2

1.90

1.95

mmol/l

0.39

197

766

Acute upper respiratory infections of multiple and unspecified sites

481

1861

1.95

38.82

1.3

1.88

2.01

mmol/l

2.28

444

1733

Extrapyramidal and movement disorders

236

937

2.54

38.65

1.2

1.3

1.95

2.15

mmol/l

3.04

219

867

Other pulmonary diagnosis

513

1315

1.96

38.55

1.4

1.2

2.02

2.07

mmol/l

0.35

478

1222

Other disorders of urethra and urinary system

442

1666

2.00

38.48

1.3

1.2

2.16

2.08

mmol/l

0.47

409

1540

Visual field defects

185

4.80

38.35

1.6

1.3

2.21

2.04

mmol/l

0.43

176

Any reimbursement code in KELA

413

979

2.12

38.22

1.3

1.2

1.96

1.88

mmol/l

0.69

388

913

Pain in limb

499

1894

1.91

38.13

1.3

1.99

2.12

mmol/l

1.50

458

1760

Subjective visual disturbances

183

644

2.87

38.06

1.2

1.3

1.78

2.06

mmol/l

6.19

162

605

Oxycodone

228

868

2.56

37.75

1.4

1.3

2.19

2.18

mmol/l

0.06

214

815

Symptoms and signs involving the digestive system and abdomen

646

1805

1.80

37.51

1.3

1.2

2.02

2.10

mmol/l

0.70

606

1663

Acute sinusitis

349

1542

2.12

37.28

1.2

1.3

2.13

2.01

mmol/l

0.84

321

1443

Symptoms and signs involving the circulatory and respiratory systems

675

1922

1.77

36.90

1.3

1.93

2.07

mmol/l

2.06

631

1784

707

2158

1.74

36.89

1.2

1.3

2.08

2.07

mmol/l

0.04

657

2003

Intestinal infectious diseases

594

2606

1.78

36.71

1.3

1.2

1.98

2.06

mmol/l

1.18

547

2415

Migraine with aura and triptan purchases

140

433

3.28

36.50

1.2

1.3

1.76

1.95

mmol/l

2.09

129

404

Primary_lymphoid and hematopoietic malignant neoplasms

169

583

2.93

36.43

1.4

1.3

2.38

2.12

mmol/l

0.90

159

546

Acute upper respiratory infections

642

2296

1.76

36.38

1.2

1.3

2.06

2.08

mmol/l

0.19

592

2131

Excluding asthma or asthma-COPD overlap

504

1315

1.93

36.07

1.4

1.2

2.02

2.07

mmol/l

0.35

471

1222

Other diseases of urinary system

640

2045

1.77

36.04

1.3

1.2

2.11

2.05

mmol/l

0.52

597

1899

Primary_lymphoid and hematopoietic malignant neoplasms

169

587

2.91

36.03

1.4

1.3

2.38

2.13

mmol/l

0.84

159

552

Sleep disorders (combined)

616

2293

1.77

35.90

1.2

1.3

1.98

2.13

mmol/l

2.26

564

2126

COPD differential diagnosis

503

1314

1.93

35.87

1.4

1.2

2.01

2.07

mmol/l

0.43

470

1222

ILD differential diagnosis

503

1314

1.93

35.86

1.4

1.2

2.01

2.07

mmol/l

0.43

470

1222

Soft tissue disorders

678

2028

1.74

35.72

1.2

1.3

1.92

2.09

mmol/l

3.28

628

1882

Systemic connective tissue disorders

237

979

2.44

35.71

1.2

1.3

2.11

2.03

mmol/l

0.41

215

904

Bronchitis

660

2523

1.72

35.14

1.2

1.3

1.97

2.08

mmol/l

1.39

614

2335

Abnormalities of breathing

578

1914

1.80

35.13

1.3

1.98

2.07

mmol/l

0.77

535

1778

Aplastic and other anaemias

264

1087

2.32

35.13

1.3

2.29

2.14

mmol/l

0.71

240

1012

Fitting and adjustment of other devices

215

790

2.55

35.10

1.2

2.34

2.16

mmol/l

0.88

194

739

Exclusions for E4_PCOS_BROAD

149

491

3.07

34.90

1.3

2.07

1.98

mmol/l

0.46

134

457

Pain in throat and chest

536

1792

1.84

34.82

1.2

1.3

1.96

2.10

mmol/l

2.11

485

1660

Disorders of other endocrine glands

294

1323

2.20

34.80

1.2

1.3

2.00

1.99

mmol/l

0.09

275

1231

Other and unspecified anaemias

244

998

2.38

34.67

1.3

2.33

2.14

mmol/l

0.89

222

929

Selective serotonin reuptake inhibitors

611

1817

1.78

34.49

1.3

1.2

1.99

2.10

mmol/l

1.62

569

1684

Other anaemias

246

1010

2.37

34.43

1.3

2.32

2.14

mmol/l

0.86

224

941

Invasive ventilation

179

4.63

34.15

1.3

1.2

2.81

1.98

mmol/l

2.62

169

Fall on same level

734

2457

1.68

34.15

1.3

2.07

2.04

mmol/l

0.26

686

2275

Diarrhoea and gastroenteritis of presumed infectious origin

446

2173

1.87

33.42

1.3

1.2

1.99

2.04

mmol/l

0.48

408

2015

Persons encountering health services for examination and investigation

399

986

2.04

33.32

1.3

1.2

2.02

2.11

mmol/l

0.70

371

919

Diseases of oesophagus, stomach and duodenum

656

2345

1.71

33.26

1.3

2.02

2.10

mmol/l

0.89

602

2179

Intracerebral haemorrhage

216

4.17

33.15

2.2

1.2

2.84

2.13

mmol/l

2.31

199

Provisional assignment of new diseases of uncertain etiology

303

1435

2.13

32.95

1.3

2.03

1.97

mmol/l

0.29

284

1343

Codes for special purposes

303

1436

2.12

32.89

1.3

2.03

1.97

mmol/l

0.29

284

1344

Brain glioblastoma and astrocytoma

12.44

32.78

1.6

1.3

2.30

1.88

mmol/l

1.32

Cerebral aneurysm, nonruptured

177

4.55

32.70

1.8

1.3

2.28

2.18

mmol/l

0.27

166

Recurrent or chronic depression

248

764

2.36

32.44

1.2

1.91

1.99

mmol/l

0.55

229

715

Acute tubulo-interstitial nephritis

377

1724

1.95

31.73

1.4

1.2

2.24

2.05

mmol/l

1.49

349

1602

Non-invasive ventilation

145

463

2.97

31.71

1.7

1.2

2.32

1.90

mmol/l

3.05

128

440

Personality disorders, excluding more controls

179

687

2.63

31.55

1.2

1.3

1.91

1.90

mmol/l

0.05

156

651

Gastro-oesophageal reflux disease

410

1930

1.89

31.50

1.3

2.04

2.13

mmol/l

0.74

374

1795

Dementia

219

616

2.47

31.30

1.2

2.04

2.33

mmol/l

2.50

201

563

Dementia, including avohilmo

237

693

2.37

31.10

1.2

2.10

2.30

mmol/l

1.09

216

636

Alzheimer’s disease, wide definition, excluding more controls

5.66

30.87

1.1

1.95

2.18

mmol/l

0.84

Viral infections characterized by skin and mucous membrane lesions

273

1276

2.15

30.72

1.3

2.21

2.01

mmol/l

0.99

262

1189

Other/unspecified dorsalgia

234

1023

2.29

30.66

1.2

1.3

2.00

2.10

mmol/l

0.61

214

955

Spondylopathies

454

1499

1.85

30.14

1.4

1.3

2.13

2.21

mmol/l

0.62

420

1396

Care involving use of rehabilitation procedures

377

1900

1.89

29.46

1.4

1.2

2.00

2.05

mmol/l

0.37

334

1782

Hypertensive diseases (excluding secondary)

342

985

2.03

29.43

1.3

1.2

2.14

1.87

mmol/l

3.14

314

917

Enlarged lymph nodes

273

3.59

29.35

1.2

1.3

2.39

2.02

mmol/l

0.75

259

Codeine or tramadol medication

700

2393

1.63

29.11

1.2

1.3

2.09

2.07

mmol/l

0.09

639

2225

Brain meningioma, excluding all cancers (controls excluding all cancers)

107

5.46

29.09

1.6

1.2

2.68

2.13

mmol/l

1.11

102

Complications of procedures, not elsewhere classified

467

2294

1.77

28.75

1.4

1.2

2.09

mmol/l

0.03

439

2120

Substance abuse

362

1831

1.90

28.61

1.3

2.18

2.06

mmol/l

0.83

335

1709

Schizophrenia or delusion, excluding more controls

193

799

2.41

28.50

1.2

1.3

2.12

1.97

mmol/l

0.63

175

755

Mental and behavioural disorders due to psychoactive substance use

369

1863

1.88

28.15

1.2

1.3

2.17

2.06

mmol/l

0.81

342

1739

Diseases of the ear and mastoid process

720

2273

1.61

28.11

1.3

1.96

2.07

mmol/l

1.66

667

2108

Exposure to unspecified factor

582

2730

1.66

28.11

1.3

2.04

2.06

mmol/l

0.12

532

2538

Any dementia, excluding more controls

177

478

2.59

27.89

1.2

2.00

2.32

mmol/l

3.32

161

437

Benign neoplasm of brain and other parts of central nervous system

146

4.62

27.84

2.1

1.1

2.65

2.08

mmol/l

1.24

136

Covid-19 confirmed case

194

827

2.37

27.40

1.4

1.2

2.15

1.99

mmol/l

0.64

180

777

Other diseases of blood and blood-forming organs, wide

155

598

2.62

27.16

1.4

1.3

2.42

2.04

mmol/l

1.38

144

564

Diseases of the myoneural junction and muscle

293

3.39

27.13

1.3

2.14

2.10

mmol/l

0.14

276

Abdominal and pelvic pain

597

1805

1.67

26.88

1.3

1.2

1.98

2.10

mmol/l

1.50

556

1663

Hypertension, essential

471

1526

1.77

26.84

1.2

1.3

2.22

1.99

mmol/l

2.61

434

1417

Benign neoplasm of brain and other parts of central nervous system

151

4.46

26.71

2.1

1.2

2.65

2.02

mmol/l

1.57

142

Visual impairment including blindness (binocular or monocular)

136

4.64

26.41

1.3

1.2

2.17

1.99

mmol/l

0.31

130

Endocrine, nutritional and metabolic diseases

518

1535

1.72

26.31

1.3

1.2

2.02

1.92

mmol/l

1.01

478

1432

Diseases of the musculoskeletal system and connective tissue

360

937

1.94

26.29

1.2

1.3

1.87

2.07

mmol/l

2.33

337

870

Antihypertensive medication - note that there are other indications

419

1261

1.83

26.25

1.3

1.2

1.90

1.87

mmol/l

0.24

387

1179

All influenza

161

643

2.52

26.24

1.2

2.11

1.98

mmol/l

0.51

147

606

Hypopituitarism

180

4.08

25.94

1.3

1.5

1.97

1.92

mmol/l

0.24

171

Other disorders of lacrimal gland

216

993

2.19

25.53

1.2

1.3

2.20

2.07

mmol/l

0.64

193

917

Other necrotizing vasculopathies

144

4.46

25.52

1.3

1.2

2.12

2.06

mmol/l

0.16

136

Disorders of lacrimal system

251

1224

2.06

25.43

1.3

2.18

2.10

mmol/l

0.38

228

1133

Temporomandibular joint disorders

100

315

3.20

25.40

1.1

1.3

1.98

1.99

mmol/l

0.02

290

External causes of morbidity and mortality

419

1159

1.82

25.38

1.4

1.2

1.96

2.08

mmol/l

1.05

388

1071

Other functional intestinal disorders

272

1299

2.01

25.26

1.3

2.00

2.13

mmol/l

1.36

246

1197

Disorders of vestibular function (Vertigo)

263

1298

2.02

25.26

1.2

1.3

1.90

2.17

mmol/l

5.17

244

1200

Other and unspecified visual disturbances

229

3.64

25.24

1.1

1.3

1.83

2.11

mmol/l

2.14

217

L04AX Other immunosuppressants

332

1791

1.86

25.00

1.2

1.3

2.18

2.06

mmol/l

0.49

311

1671

Disorders of lipoprotein metabolism and other lipidaemias

433

1551

1.76

24.97

1.3

2.22

2.13

mmol/l

0.50

397

1436

Encephalopathy

19.26

24.91

1.2

1.1

1.90

1.72

mmol/l

0.69

Bipolar affective disorders

141

543

2.62

24.84

1.2

1.3

2.04

1.90

mmol/l

0.49

134

510

Other disorders of nervous system

131

4.59

24.79

1.6

1.2

2.24

2.22

mmol/l

0.03

123

Asthma (mode)

425

1314

1.78

24.74

1.3

1.2

2.05

2.07

mmol/l

0.08

389

1222

Diseases of pulp and periapical tissues

226

1072

2.12

24.67

1.3

2.14

2.13

mmol/l

0.06

211

997

Pneumonitis due to solids and liquids

152

4.27

24.67

1.9

1.2

2.42

2.06

mmol/l

0.84

139

Second line medication for Crohn's disease

339

1851

1.84

24.57

1.2

1.3

2.17

2.06

mmol/l

0.49

317

1722

Gastrointestinal diseases

406

1126

1.81

24.43

1.3

1.95

2.01

mmol/l

0.43

377

1037

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

211

980

2.17

24.34

1.4

1.3

2.00

1.91

mmol/l

0.62

189

922

Cystitis

493

1793

1.69

24.26

1.3

1.2

2.01

2.06

mmol/l

0.43

457

1661

Cervicalgia

135

515

2.64

24.24

1.2

1.3

1.99

2.08

mmol/l

0.39

121

484

Other necrotizing vasculopathies (FG)

118

4.75

24.10

1.3

2.13

2.07

mmol/l

0.14

113

Migraine, single triptan purchase ok & required. ICD-code if available is included

479

1932

1.69

23.97

1.2

1.3

1.81

2.05

mmol/l

7.81

441

1806

Triptan medication for migraine, single purchase ok

479

1932

1.69

23.97

1.2

1.3

1.81

2.05

mmol/l

7.81

441

1806

Other and unspecified nonorganic psychotic disorders

149

600

2.51

23.96

1.2

1.3

2.13

1.90

mmol/l

0.92

135

554

Spondylosis

291

1300

1.93

23.80

1.4

1.3

2.03

2.25

mmol/l

2.52

270

1211

Asthma, excluding more controls

418

1261

1.77

23.76

1.3

1.2

2.05

2.06

mmol/l

0.04

385

1174

Hypothyroidism, strict autoimmune

403

1518

1.76

23.66

1.2

1.3

1.98

2.12

mmol/l

1.49

364

1408

Diagnoses used for exclusion with ILD

160

674

2.39

23.31

1.6

1.2

2.29

2.09

mmol/l

0.97

152

635

Asthma

424

1302

1.75

23.23

1.3

1.2

2.05

2.07

mmol/l

0.06

390

1210

Other systemic involvement of connective tissue (FG)

161

677

2.38

23.16

1.2

1.3

2.06

mmol/l

0.01

148

631

L04AA Selective immunosuppressants

153

635

2.43

23.07

1.2

1.4

2.29

2.02

mmol/l

0.63

144

594

343

1755

1.80

22.99

1.2

1.3

2.13

2.08

mmol/l

0.30

319

1630

Factors influencing health status and contact with health services

180

375

2.42

22.68

1.4

1.2

2.03

2.12

mmol/l

0.38

170

347

Alcohol use disorder, Swedish definition

323

1649

1.83

22.66

1.2

1.3

2.18

2.08

mmol/l

0.61

296

1536

Other disorders of bladder

256

3.32

22.61

1.2

2.11

2.05

mmol/l

0.16

240

Other intervertebral disc disorders

459

1676

1.68

22.43

1.2

1.3

1.96

2.17

mmol/l

2.94

427

1555

Pure hypercholesterolaemia

374

1421

1.77

22.40

1.3

2.15

2.13

mmol/l

0.13

346

1319

Neoplasms

499

1621

1.66

22.30

1.3

1.2

2.05

1.89

mmol/l

1.94

466

1504

Transient ischemic attack

253

1063

1.98

22.29

1.2

1.3

2.03

2.22

mmol/l

2.05

234

980

Dysphagia

143

585

2.46

22.24

1.5

1.3

2.18

2.12

mmol/l

0.20

132

545

Other and unspecified myopathies

178

3.82

22.22

1.2

1.4

2.08

2.07

mmol/l

0.01

168

356

1814

1.77

22.17

1.2

1.3

2.14

2.07

mmol/l

0.47

329

1688

Asthma, unspecified (mode), excluding more controls

274

1119

1.93

22.17

1.3

1.2

2.21

2.07

mmol/l

0.69

251

1043

Non-selective monoamine reuptake inhibitors

209

972

2.10

22.10

1.3

1.2

2.06

2.15

mmol/l

0.60

193

905

Sleep apnoea

509

2139

1.62

21.94

1.2

1.3

2.04

2.16

mmol/l

1.34

466

1981

Any dementia

181

564

2.27

21.90

1.2

1.99

2.30

mmol/l

3.57

165

512

Disorders of eyelid, lacrimal system and orbit

466

2232

1.64

21.86

1.3

2.17

2.09

mmol/l

0.57

425

2070

Pain in thoracic spine

105

372

2.85

21.81

1.5

1.4

1.84

2.08

mmol/l

1.89

100

352

Accidents

498

1517

1.65

21.63

1.3

1.99

2.08

mmol/l

0.83

461

1406

Mental and behavioural disorders due to alcohol

300

1597

1.84

21.62

1.2

1.3

2.15

2.07

mmol/l

0.44

277

1493

Mycoses

166

736

2.27

21.54

1.3

2.54

2.03

mmol/l

1.36

151

693

Other acute lower respiratory infections

305

1602

1.83

21.47

1.2

1.3

1.98

2.03

mmol/l

0.33

282

1490

Other specific joint derangements/joint disorders

441

1777

1.67

21.39

1.1

1.3

1.95

2.02

mmol/l

0.58

402

1648

Falls/tendency to fall

658

2152

1.54

21.25

1.3

1.2

2.04

mmol/l

0.01

615

1993

Asthma, unspecified (mode)

275

1153

1.90

21.23

1.3

1.2

2.21

2.08

mmol/l

0.63

252

1072

Mental and behavioural disorders due to alcohol, excluding acute intoxication

260

1373

1.90

20.98

1.2

1.3

2.20

2.07

mmol/l

0.70

237

1289

Cervical disc disorders

206

1005

2.06

20.95

1.4

1.3

2.05

2.19

mmol/l

0.98

193

936

Somatoform disorder

114

431

2.67

20.93

1.2

1.84

1.99

mmol/l

0.82

101

403

Other external causes of accidental injury

494

1517

1.64

20.82

1.3

1.98

2.08

mmol/l

0.96

459

1406

Abnormalities of heart beat

207

1009

2.04

20.57

1.2

1.3

2.02

2.10

mmol/l

0.30

196

937

Sleep apnoea, including avohilmo

538

2223

1.58

20.56

1.2

1.3

2.06

2.14

mmol/l

0.71

494

2057

Emotional disorders starting during childhood or adolecense, excluding more controls

4.92

20.51

1.5

1.2

1.74

1.62

mmol/l

0.47

Other systemic involvement of connective tissue

164

742

2.23

20.29

1.2

1.3

2.06

2.05

mmol/l

0.02

151

683

Diseases of inner ear

287

1550

1.82

20.19

1.2

1.3

1.92

2.20

mmol/l

5.33

266

1431

Alcohol use disorder, ICD-based

239

1246

1.93

20.15

1.2

1.3

2.20

2.04

mmol/l

0.88

217

1169

Acute bronchitis

231

1166

1.95

20.10

1.2

1.3

1.92

2.03

mmol/l

0.96

212

1080

Supplementary factors related to causes of morbidity and mortality classified elsewhere

189

910

2.09

19.97

1.4

1.3

2.07

2.00

mmol/l

0.30

175

853

Hypertension

458

1590

1.64

19.84

1.2

1.3

2.16

1.99

mmol/l

2.05

423

1474

Hypertensive diseases

458

1591

1.63

19.81

1.2

1.3

2.16

1.98

mmol/l

2.06

423

1475

Dissociative [conversion] disorders

5.05

19.77

1.2

1.97

1.91

mmol/l

0.10

Other joint disorders

536

1818

1.58

19.68

1.2

1.3

1.89

2.03

mmol/l

2.17

503

1684

Other and unspecified nerve root and plexus disorders, also in other diseases

121

486

2.51

19.66

1.2

1.3

1.88

2.03

mmol/l

0.85

111

455

Dental caries

164

745

2.20

19.60

1.2

1.3

2.09

2.06

mmol/l

0.12

153

699

Other viral diseases

198

975

2.04

19.54

1.2

1.3

1.98

1.90

mmol/l

0.41

187

905

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

535

2345

1.56

19.54

1.3

1.2

2.17

2.05

mmol/l

1.20

497

2180

Arthropathies

557

1822

1.56

19.45

1.1

1.3

1.94

2.03

mmol/l

0.96

522

1688

Diseases of the respiratory system

369

1069

1.74

19.34

1.3

1.2

2.04

2.05

mmol/l

0.07

343

995

Sciatica+with lumbago

268

1392

1.84

19.29

1.2

1.3

1.92

2.18

mmol/l

3.92

249

1295

Other symptoms and signs involving the digestive system and abdomen

104

392

2.68

19.24

1.2

1.3

2.17

2.05

mmol/l

0.33

362

Other strabismus

149

661

2.27

19.24

1.3

1.87

1.93

mmol/l

0.36

134

622

Type of accident

176

837

2.12

19.23

1.5

1.3

2.01

mmol/l

0.02

162

783

Transport accidents

263

1266

1.85

19.18

1.2

1.3

1.94

2.06

mmol/l

0.93

244

1182

Constipation

467

2107

1.59

19.08

1.3

2.06

2.13

mmol/l

0.67

427

1954

Examination and observation for other reasons

291

975

1.82

18.77

1.3

1.2

2.14

2.11

mmol/l

0.10

270

912

Unspecified fall

269

1480

1.81

18.68

1.2

1.3

1.99

2.04

mmol/l

0.38

250

1372

Inflammatory diseases of female pelvic organs

346

1537

1.70

18.56

1.3

1.93

2.04

mmol/l

1.43

306

1433

Radiculopathy

103

394

2.64

18.53

1.1

1.3

2.00

2.14

mmol/l

0.64

370

Substance use, excluding alcohol

133

574

2.34

18.48

1.3

2.12

1.98

mmol/l

0.76

123

536

Other acute disseminated demyelination

9.66

18.37

1.1

1.3

1.71

1.80

mmol/l

0.28

Chronic periapical parodontitis

133

578

2.32

18.19

1.3

2.27

2.16

mmol/l

0.36

123

540

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

295

1659

1.75

18.15

1.2

1.3

1.98

2.12

mmol/l

1.48

274

1548

Sensorineural hearing loss

379

1607

1.66

18.09

1.3

2.19

2.17

mmol/l

0.11

349

1493

Other extrapyramidal and movement disorders in other diseases

130

561

2.34

18.07

1.2

1.3

1.95

2.10

mmol/l

1.07

125

524

Speech and linguistic disorders, excluding more controls

164

3.54

17.98

1.4

1.3

2.02

1.76

mmol/l

1.19

154

Certain disorders involving the immune mechanism

127

545

2.35

17.90

1.5

1.3

2.19

2.04

mmol/l

0.59

122

513

350

2.71

17.87

1.8

1.2

1.96

mmol/l

0.00

327

Other bacterial intestinal infections

108

431

2.53

17.83

1.3

2.09

mmol/l

0.00

398

Alzheimer’s disease (Late onset), excluding more controls

4.53

17.54

1.2

1.1

2.08

2.09

mmol/l

0.02

Renal failure

213

1023

1.91

17.35

1.2

1.3

2.25

2.17

mmol/l

0.30

191

956

Dentinal caries

145

663

2.19

17.34

1.2

1.3

2.11

2.07

mmol/l

0.17

134

624

Unspecified mental disorder

247

1368

1.81

17.30

1.2

1.3

2.10

1.99

mmol/l

0.52

228

1281

Benign neoplasms

458

1647

1.58

17.27

1.3

1.2

1.99

1.92

mmol/l

0.72

426

1533

Injury, poisoning and certain other consequences of external causes

317

910

1.75

17.24

1.4

1.2

1.98

2.02

mmol/l

0.21

294

836

Retention of urine

176

731

2.05

17.15

1.4

1.2

2.20

2.19

mmol/l

0.05

158

681

Follow-up examination after treatment for conditions other than malignant neoplasms

224

771

1.91

17.08

1.2

1.3

1.99

2.09

mmol/l

0.60

206

718

Non-Hodgkin lymphoma, all

5.33

17.07

1.5

1.1

3.21

1.96

mmol/l

1.15

Unspecific neurodegenerative disorder

176

588

2.07

17.04

1.2

2.03

2.30

mmol/l

2.10

163

534

Diseases of the skin and subcutaneous tissue

586

1968

1.50

17.00

1.3

1.2

2.03

2.05

mmol/l

0.18

550

1818

Nutritional anaemias

247

1338

1.80

16.93

1.2

1.3

2.11

mmol/l

0.01

224

1241

Lumbar disc prolapse

333

1588

1.67

16.92

1.2

1.3

1.94

2.18

mmol/l

2.99

311

1474

Type 2 diabetes, wide definition

409

1670

1.60

16.88

1.2

1.3

2.46

2.08

mmol/l

3.49

371

1550

Degenerative diseases of the nervous system

149

515

2.19

16.87

1.2

1.97

2.23

mmol/l

3.42

137

469

Disorders of the thyroid gland

524

2270

1.51

16.87

1.2

2.01

2.07

mmol/l

0.62

477

2114

Kela-code for severe mental illness

222

1200

1.86

16.86

1.2

1.3

2.05

2.00

mmol/l

0.23

204

1123

Coxibs

175

441

2.12

16.85

1.2

1.82

2.16

mmol/l

4.54

162

407

Fibromyalgia

204

3.22

16.80

1.3

1.5

1.99

2.03

mmol/l

0.06

195

Other shoulder lesions

204

3.22

16.79

1.3

1.4

1.86

2.05

mmol/l

1.16

191

Infections of the skin and subcutaneous tissue

321

1923

1.67

16.75

1.2

1.3

2.03

2.04

mmol/l

0.06

299

1785

Diseases of liver

188

966

1.96

16.67

1.2

1.3

2.35

2.05

mmol/l

1.47

174

910

Other CVD (FINNGEN)

159

3.30

16.65

1.3

1.2

2.10

1.97

mmol/l

0.33

148

Meningitis, viral

34.23

16.58

1.5

1.1

2.44

1.65

mmol/l

—

Asthma (only as main-diagnosis), excluding more controls

351

1261

1.66

16.54

1.3

1.2

1.98

2.06

mmol/l

0.56

318

1174

Personality disorders

179

907

1.99

16.54

1.2

1.3

1.91

1.93

mmol/l

0.13

156

854

Genitourinary diseases

358

1078

1.67

16.48

1.3

1.2

1.93

2.01

mmol/l

0.59

337

997

Leisure time condition

117

503

2.35

16.47

1.6

1.3

1.93

2.01

mmol/l

0.43

106

469

Other and unspecified iron deficiency

172

861

2.01

16.42

1.2

1.3

2.06

mmol/l

0.00

154

798

Other disorders of glucose regulation and pancreatic internal secretion

197

3.24

16.39

1.1

1.3

2.06

2.02

mmol/l

0.13

187

Triptan medication for migraine, min. 3 purchases

329

1567

1.66

16.37

1.2

1.3

1.81

1.97

mmol/l

2.76

305

1461

Schizophrenia, schizotypal and delusional disorders

195

1022

1.92

16.32

1.2

1.3

2.12

1.97

mmol/l

0.64

177

954

Finngen Rheumatological endpoints

558

2142

1.49

16.24

1.2

1.3

2.04

mmol/l

0.01

516

1990

Suicide or other Intentional self-harm

161

791

2.05

16.23

1.3

2.01

1.97

mmol/l

0.20

141

741

Other disorders of ear

480

2100

1.53

16.23

1.2

1.3

2.12

mmol/l

0.02

441

1952

Use of hypnotics and sedatives

592

2335

1.47

16.21

1.3

1.2

2.07

2.09

mmol/l

0.12

546

2172

Hypothyroidism, other/unspecified

489

2129

1.52

16.17

1.2

1.3

2.02

2.07

mmol/l

0.41

445

1980

Other diseases of intestines

601

2392

1.46

16.15

1.3

1.99

2.06

mmol/l

0.69

559

2224

Disorders of adult personality and behaviour

186

965

1.94

16.06

1.2

1.3

1.93

1.92

mmol/l

0.04

162

905

Conductive and sensorineural hearing loss

395

1727

1.59

16.01

1.2

1.3

2.18

2.15

mmol/l

0.15

363

1603

Iron deficiency anaemia

214

1151

1.85

16.00

1.2

1.3

2.11

2.07

mmol/l

0.16

193

1073

Open wound of head

265

1511

1.73

15.95

1.3

2.00

2.09

mmol/l

0.69

250

1408

Presence of other functional implants

274

1116

1.75

15.94

1.2

1.3

2.20

2.25

mmol/l

0.22

254

1035

Polyarthropathies

371

1537

1.61

15.92

1.2

1.3

2.24

2.08

mmol/l

0.87

346

1422

Injuries to the thorax

230

1280

1.80

15.90

1.3

2.06

2.12

mmol/l

0.28

204

1196

Asthma (only as main-diagnosis)

353

1302

1.64

15.85

1.3

1.2

1.98

2.07

mmol/l

0.63

320

1210

Schizophrenia or delusion

193

1021

1.90

15.72

1.2

1.3

2.12

1.97

mmol/l

0.65

175

953

Nonorganic sleeping disorders, excluding more controls

107

453

2.38

15.60

1.2

1.73

1.92

mmol/l

2.69

424

Generalized anxiety disorder

105

441

2.40

15.60

1.1

1.2

1.76

1.90

mmol/l

1.71

100

410

Hypothyreosis and Thyroxine purchase for inclusion criteria

501

2211

1.50

15.55

1.2

1.3

2.01

2.07

mmol/l

0.50

455

2057

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

191

1012

1.90

15.50

1.4

1.3

2.12

2.01

mmol/l

0.65

176

943

Use of levodopa decarboxylase inhibitor

274

2.80

15.43

1.1

1.2

1.91

2.12

mmol/l

2.30

255

Dermatitis and eczema

595

2703

1.45

15.41

1.3

1.2

2.06

mmol/l

0.01

549

2506

Internal derangement of knee

212

1160

1.83

15.39

1.3

1.90

2.08

mmol/l

2.41

195

1077

Hypoglycaemia, other or unspecified

160

3.42

15.34

1.1

1.4

2.05

2.01

mmol/l

0.11

152

Disorders of mineral metabolism

181

3.25

15.18

1.3

2.29

2.07

mmol/l

0.45

171

Poisoning by medicine

142

684

2.09

15.14

1.2

1.3

1.91

1.93

mmol/l

0.14

127

642

Pain and other conditions associated with female genital organs and menstrual cycle

135

610

2.14

15.13

1.3

1.2

1.89

1.94

mmol/l

0.21

122

564

Hypothyroidism, drug reimbursement

201

2.83

15.09

1.3

1.1

2.06

1.75

mmol/l

2.41

190

Bacterial intestinal infections, IBD co-morbidities

105

451

2.35

14.85

1.3

2.10

2.08

mmol/l

0.07

419

Lung diseases due to external agents

297

2.68

14.81

1.7

1.2

2.33

2.06

mmol/l

0.76

276

248

1430

1.73

14.79

1.2

1.3

2.09

1.97

mmol/l

0.62

232

1333

Dementia in Alzheimer disease

221

2.84

14.76

1.2

2.03

2.25

mmol/l

1.37

199

Poisoning by drugs, medicaments and biological substances

153

766

2.01

14.70

1.2

1.3

1.89

1.95

mmol/l

0.41

137

717

Post-traumatic stress disorder

211

3.02

14.65

1.3

1.2

1.87

1.82

mmol/l

0.14

200

Insulin, intermediate and long-acting

280

1654

1.67

14.60

1.2

1.3

2.41

2.05

mmol/l

4.69

258

1539

Tetraplegia

12.20

14.55

4.2

1.1

1.88

1.71

mmol/l

0.26

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

246

891

1.76

14.40

1.2

2.17

1.87

mmol/l

3.39

231

830

Injuries to the ankle and foot

383

2268

1.54

14.36

1.2

1.3

1.89

2.00

mmol/l

1.36

350

2116

Other and unspecified effects of external causes

169

883

1.93

14.36

1.2

1.3

1.78

1.95

mmol/l

2.80

156

826

Hyperlipidaemia, other/unspecified

180

906

1.89

14.33

1.2

1.3

2.14

2.20

mmol/l

0.25

165

838

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

116

530

2.21

14.21

1.2

1.3

1.95

1.94

mmol/l

0.01

101

496

Emotional disorders starting during childhood or adolescence

128

3.62

14.21

1.5

1.2

1.72

1.68

mmol/l

0.14

117

Volume depletion

163

3.28

14.20

1.2

2.47

2.01

mmol/l

1.08

157

Any event in cancer register

497

2001

1.48

14.11

1.4

1.3

2.24

2.01

mmol/l

2.97

467

1865

Other medical care

196

1053

1.83

14.10

1.5

1.2

2.60

2.07

mmol/l

2.61

181

986

Candidiasis

352

2.49

14.08

1.2

1.3

2.29

2.03

mmol/l

0.90

329

Cough

214

1161

1.78

14.02

1.3

2.07

2.14

mmol/l

0.30

197

1072

Urticaria and erythema

211

1193

1.78

13.93

1.2

1.3

2.07

1.97

mmol/l

0.38

186

1117

Dementia in other diseases classified elsewhere

4.77

13.79

1.3

1.2

1.92

2.05

mmol/l

0.34

Other problems related to primary support group, including family circumstances

347

2.47

13.69

1.7

1.2

1.85

1.84

mmol/l

0.04

323

Osteopathies and chondropathies

278

1611

1.64

13.68

1.2

1.3

2.03

2.10

mmol/l

0.58

258

1495

Excessive, frequent and irregular menstruation

241

767

1.76

13.67

1.4

1.2

2.00

1.98

mmol/l

0.12

232

709

Special screening examination for infectious and parasitic diseases

140

512

2.05

13.57

1.2

1.70

1.94

mmol/l

2.56

128

480

Behavioural syndromes associated with physiological disturbances and physical factors

191

1059

1.81

13.46

1.2

1.3

1.84

1.92

mmol/l

0.50

179

989

Insulin medication

307

1645

1.60

13.42

1.2

1.3

2.40

2.02

mmol/l

5.96

283

1531

Specific personality disorders

152

785

1.95

13.41

1.2

1.3

1.87

1.91

mmol/l

0.33

131

735

Polycystic ovarian syndrome, consortium definition

382

1500

1.54

13.32

1.4

1.2

2.08

2.00

mmol/l

0.61

360

1385

Insulin, fast-acting

193

1077

1.80

13.31

1.2

1.3

2.36

2.00

mmol/l

3.02

176

1012

Use of anticholinesterases

130

508

2.08

13.28

1.2

2.05

2.25

mmol/l

1.00

120

459

N06DA Anticholinesterases

130

508

2.08

13.28

1.2

2.05

2.25

mmol/l

1.00

120

459

Other disorders of eye and adnexa

375

2.39

13.22

1.3

1.89

2.00

mmol/l

0.62

350

Shoulder lesions

395

1591

1.52

13.17

1.3

1.97

2.20

mmol/l

5.18

364

1476

Noninfective enteritis and colitis

251

1514

1.66

13.07

1.3

2.02

2.01

mmol/l

0.04

232

1415

Irritable bowel syndrome

160

849

1.89

13.02

1.2

1.3

1.84

2.00

mmol/l

2.52

143

791

Other disorders of skin and subcutaneous tissue

333

1970

1.55

12.95

1.3

2.17

2.13

mmol/l

0.18

303

1829

Vocal cord dysfunction

266

2.60

12.94

1.3

2.13

1.92

mmol/l

0.58

252

Heterophoria

189

3.00

12.90

1.4

1.2

1.84

1.85

mmol/l

0.08

175

Insulin, combination of fast acting with intermediate-acting or long-acting

307

1797

1.58

12.87

1.2

1.3

2.40

2.05

mmol/l

5.28

283

1675

Exclusions for E4_PCOS_CONSORTIUM

400

1665

1.51

12.84

1.2

1.3

2.03

1.98

mmol/l

0.31

367

1537

Diabetic retinopathy, excluding more controls

136

370

2.08

12.81

1.2

1.3

2.23

2.29

mmol/l

0.32

125

339

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

201

2.92

12.75

1.1

1.2

2.06

1.93

mmol/l

0.23

186

Mental and behavioural disorders due to opioids

3.88

12.66

1.3

1.6

1.91

1.85

mmol/l

0.17

Other disorders of teeth and supporting structures

122

596

2.06

12.62

1.2

1.3

2.17

2.14

mmol/l

0.10

112

561

Convergent concomitant strabismus

145

3.28

12.60

1.1

1.3

1.88

1.83

mmol/l

0.11

136

Diseases of arteries, arterioles and capillaries (FINNGEN)

121

403

2.11

12.43

1.3

1.2

2.33

1.95

mmol/l

2.89

112

377

Cardiac arrhythmias

317

1338

1.57

12.28

1.2

2.08

1.90

mmol/l

1.37

294

1257

Secondary hypertension

151

3.18

12.23

1.2

2.14

1.89

mmol/l

0.45

143

Other and unspecified tonsillitis

196

950

1.76

12.22

1.2

1.80

1.92

mmol/l

0.97

178

895

Asthma, hospital admission 2, infections

301

1900

1.56

12.20

1.2

1.3

2.13

2.03

mmol/l

0.53

277

1769

Asthma-related infections

301

1900

1.56

12.20

1.2

1.3

2.13

2.03

mmol/l

0.53

277

1769

Spinal stenosis

229

1068

1.69

12.16

1.3

2.16

2.28

mmol/l

0.79

212

995

Erysipelas

243

1349

1.65

12.15

1.2

1.3

2.28

2.06

mmol/l

1.78

227

1250

Functional dyspepsia

142

742

1.92

12.14

1.1

1.3

2.02

2.03

mmol/l

0.03

136

696

Presence of other devices

108

512

2.12

12.08

1.4

1.2

2.57

2.18

mmol/l

1.24

475

Insulin, fast-acting or short human

194

1117

1.74

12.07

1.2

1.3

2.37

2.03

mmol/l

2.78

177

1050

Abnormal findings on examination of blood, without diagnosis

225

1260

1.68

12.05

1.2

1.3

2.25

2.13

mmol/l

0.67

211

1174

Familial hypercholesterolemia

332

2.40

11.83

1.2

2.15

2.14

mmol/l

0.02

314

Other noninfective gastroenteritis and colitis

138

721

1.92

11.79

1.3

2.12

2.01

mmol/l

0.51

122

674

Panic disorder

433

2.21

11.79

1.2

1.3

1.88

1.89

mmol/l

0.04

407

Abnormal findings on diagnostic imaging of other body structures

315

2.43

11.76

1.3

1.97

2.14

mmol/l

0.74

296

Exposure to other specified factors

388

2482

1.47

11.70

1.3

1.96

2.04

mmol/l

0.91

356

2309

Benign paroxysmal vertigo

144

766

1.89

11.69

1.2

1.3

1.95

2.13

mmol/l

1.33

137

712

Chronic kidney disease

133

686

1.94

11.66

1.2

1.3

2.36

2.19

mmol/l

0.47

119

645

Disorders of choroid and retina

380

1867

1.49

11.66

1.3

2.23

2.15

mmol/l

0.54

347

1730

Emotional disorders and disorders of social functioning with onset specific to childhood

150

3.13

11.65

1.4

1.2

1.73

1.69

mmol/l

0.13

137

Benign neoplasms

537

2139

1.40

11.65

1.3

1.2

2.04

2.01

mmol/l

0.17

503

1992

Superficial injury of lower leg

137

719

1.92

11.59

1.2

1.3

1.93

1.97

mmol/l

0.14

124

671

Dental pulpitis 4

584

2195

1.38

11.50

1.3

1.99

2.06

mmol/l

0.72

531

2047

Dental pulpitis 1

584

2196

1.38

11.48

1.3

1.99

2.06

mmol/l

0.72

531

2049

Type 1 diabetes

146

785

1.87

11.42

1.2

1.3

2.32

1.87

mmol/l

1.38

133

739

Focal brain injury

4.53

11.41

1.6

1.1

2.32

2.08

mmol/l

0.64

Other arthritis (FG)

159

881

1.81

11.34

1.2

1.3

2.24

2.03

mmol/l

0.52

154

819

Diseases of pulp and periapical tissues, including avohilmo

582

2193

1.38

11.30

1.3

1.99

2.06

mmol/l

0.72

529

2046

Dermatitis

300

1963

1.53

11.21

1.3

2.11

2.09

mmol/l

0.09

277

1825

Irregular menses

257

1309

1.60

11.17

1.3

1.2

1.98

1.95

mmol/l

0.17

236

1212

Infections with a predominantly sexual mode of transmission

182

1055

1.73

11.11

1.2

1.3

1.81

1.91

mmol/l

1.12

167

994

Other heart diseases

245

997

1.63

11.09

1.4

1.2

2.23

1.85

mmol/l

2.88

231

934

Emotionally unstable personality disorder

393

2.23

11.08

1.1

1.4

1.88

1.85

mmol/l

0.16

367

Other and unspecified urticaria

116

587

1.99

10.96

1.2

1.3

2.12

1.94

mmol/l

0.41

105

546

Other viral diseases, not elsewhere classified

114

574

1.99

10.84

1.2

1.3

1.96

1.94

mmol/l

0.06

109

538

Injuries to the wrist and hand

518

2721

1.38

10.78

1.2

1.3

1.95

2.06

mmol/l

1.47

478

2528

Other specified/unspecified arthritis

138

746

1.86

10.70

1.2

1.3

2.10

2.01

mmol/l

0.17

133

691

Enterocolitis due to Clostridium difficile

227

2.62

10.69

1.2

1.3

2.09

2.08

mmol/l

0.03

211

Other nutritional deficiencies

330

2175

1.49

10.67

1.1

1.3

2.13

2.01

mmol/l

0.85

299

2031

Urticaria

170

982

1.74

10.57

1.2

1.3

2.04

1.94

mmol/l

0.27

151

923

Disorders of lens

322

1346

1.51

10.56

1.3

2.22

2.17

mmol/l

0.27

307

1253

Injuries to the abdomen, lower back, lumbar spine and pelvis

192

1140

1.68

10.50

1.2

1.3

2.07

2.04

mmol/l

0.12

176

1065

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

451

1886

1.42

10.45

1.4

1.3

2.18

2.06

mmol/l

1.23

421

1748

Other retinal disorders

285

1496

1.53

10.42

1.3

2.18

2.17

mmol/l

0.08

258

1385

Malignant neoplasm, wide definition for exclusion

451

1887

1.42

10.42

1.4

1.3

2.18

2.06

mmol/l

1.23

421

1749

Obesity related asthma

172

1003

1.72

10.35

1.2

1.3

2.19

2.06

mmol/l

0.44

161

937

Diabetic retinopathy, strict definition

398

2.11

10.33

1.1

1.3

2.32

2.31

mmol/l

0.03

364

Acute renal failure

484

2.06

10.31

1.3

2.27

2.13

mmol/l

0.34

455

Disorders of skin appendages

250

1603

1.56

10.28

1.3

1.99

1.98

mmol/l

0.06

235

1492

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

450

1888

1.41

10.25

1.4

1.3

2.18

2.06

mmol/l

1.25

420

1750

Menorrhagia

200

654

1.70

10.25

1.5

1.2

2.08

2.04

mmol/l

0.16

190

603

Speech and linguistic disorders

239

2.51

10.23

1.4

1.3

2.02

1.71

mmol/l

1.67

219

Other disorders of skin and subcutaneous tissue, not elsewhere classified

355

2.24

10.21

1.1

1.3

1.99

2.09

mmol/l

0.28

332

Fracture of rib(s), sternum and thoracic spine

139

765

1.83

10.20

1.4

1.3

1.93

2.14

mmol/l

2.16

127

724

Care involving dialysis

171

2.84

10.11

1.3

2.03

2.07

mmol/l

0.09

163

Disorders of psychological development

341

2.22

10.06

1.4

1.3

1.85

1.76

mmol/l

0.44

318

Malignant neoplasm

448

1892

1.41

10.05

1.3

2.21

2.07

mmol/l

1.70

420

1760

Sequelae of injuries of head

129

3.14

10.05

1.7

1.4

1.99

2.05

mmol/l

0.15

124

Sleep disorders

124

664

1.88

9.95

1.2

1.3

1.75

1.96

mmol/l

2.37

114

617

All influenza (not pneumonia)

380

2.17

9.84

1.2

1.3

2.11

1.94

mmol/l

0.40

354

severe traumatic brain injury, does not include concussion

107

549

1.96

9.76

1.5

1.3

2.36

2.12

mmol/l

0.83

517

Dystonia

121

3.18

9.75

1.2

1.4

1.76

2.09

mmol/l

1.45

115

Other infectious diseases

169

2.81

9.75

1.2

1.4

1.86

2.03

mmol/l

1.16

159

Dyspnoea

433

2380

1.40

9.71

1.3

2.02

2.10

mmol/l

0.60

397

2210

Other and unspecified dermatitis

246

1594

1.55

9.70

1.3

2.10

2.08

mmol/l

0.07

228

1488

Acute pharyngitis

412

2.11

9.70

1.3

1.91

mmol/l

0.02

387

Hypotension

331

2.25

9.68

1.3

2.06

2.19

mmol/l

0.47

309

Insomnia

485

2.01

9.55

1.3

1.79

1.97

mmol/l

1.24

455

Hypothyroidism, strict autoimmune, 3 medication purchases required

423

2065

1.40

9.47

1.2

1.3

1.98

2.07

mmol/l

0.91

382

1922

Type 1 diabetes, wide definition, subgroup 1

121

654

1.86

9.42

1.2

1.3

2.17

1.87

mmol/l

3.71

109

617

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

167

2.78

9.38

1.4

1.2

2.31

2.16

mmol/l

0.23

156

Injuries to the shoulder and upper arm

403

2416

1.40

9.38

1.3

2.10

mmol/l

0.00

378

2230

Alcohol dependence

135

757

1.79

9.36

1.2

1.3

1.99

2.05

mmol/l

0.43

122

710

Cellulitis

115

615

1.88

9.30

1.3

2.03

2.00

mmol/l

0.17

108

575

Inflammatory disease of uterus

411

2.08

9.19

1.1

1.3

1.82

1.91

mmol/l

0.51

389

Chronic sinusitis

214

1361

1.58

9.18

1.2

1.3

2.00

2.09

mmol/l

0.72

192

1274

Other diseases of hard tissues of teeth

331

1705

1.45

9.17

1.3

2.02

2.07

mmol/l

0.35

303

1590

Glomerular diseases

494

1.98

9.09

1.1

1.3

2.08

2.06

mmol/l

0.05

465

Benign neoplasm of other and unspecified endocrine glands

315

2.24

9.08

1.2

2.11

2.06

mmol/l

0.10

296

Monoplegia

6.40

9.03

1.4

1.2

1.80

1.82

mmol/l

0.03

Any operation in hilmo

13.16

8.98

1.2

1.0

1.74

1.71

mmol/l

—

Coagulation defects, purpura and other haemorrhagic conditions

104

545

1.92

8.97

1.4

1.3

2.36

1.99

mmol/l

0.91

506

Dental caries, including avohilmo

394

1429

1.41

8.83

1.3

2.04

2.11

mmol/l

0.59

374

1325

Dental caries 1

394

1429

1.41

8.82

1.3

2.04

2.11

mmol/l

0.59

374

1325

Other CVD

411

2.05

8.79

1.3

1.2

2.06

2.17

mmol/l

0.44

384

Other and unspecified drugs and medicaments

215

2.49

8.71

1.1

1.3

2.08

1.97

mmol/l

0.17

200

Type 1 diabetes, wide definition

123

686

1.80

8.69

1.2

1.3

2.16

1.87

mmol/l

3.50

111

647

Parkinson's disease, including avohilmo

354

2.13

8.65

1.2

1.94

2.18

mmol/l

2.18

334

Disorders of sclera, cornea, iris and ciliary body

261

1759

1.49

8.62

1.2

1.3

2.05

mmol/l

0.00

246

1633

Polyuria

106

567

1.88

8.60

1.3

1.2

2.04

2.13

mmol/l

0.29

529

Temporomandibular joint disorders, including avohilmo

220

1429

1.54

8.60

1.2

1.3

1.94

1.93

mmol/l

0.05

197

1334

Rheumatism, unspecified

342

2.15

8.59

1.4

2.11

2.17

mmol/l

0.11

320

Osteoporosis

110

567

1.86

8.57

1.2

1.3

2.16

2.19

mmol/l

0.12

103

521

Diabetes mellitus

522

2338

1.33

8.53

1.2

1.3

2.28

1.99

mmol/l

5.93

473

2174

Drug-induced systemic lupus erythematosus

7.84

8.49

1.2

1.3

2.09

2.03

mmol/l

0.10

Disorders of refraction and accommodation

137

792

1.73

8.48

1.4

1.3

1.99

1.93

mmol/l

0.26

126

745

Injuries to the knee and lower leg

605

2654

1.31

8.47

1.2

1.3

2.01

2.07

mmol/l

0.60

571

2453

Parkinson's disease

331

2.16

8.46

1.2

1.94

2.16

mmol/l

1.91

312

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

197

1253

1.58

8.45

1.2

1.3

1.80

1.92

mmol/l

1.38

180

1181

Other female pelvic inflammatory diseases

445

1.99

8.45

1.2

1.3

1.95

2.06

mmol/l

0.54

419

Diseases of middle ear and mastoid

306

1740

1.44

8.44

1.2

1.3

2.07

1.93

mmol/l

0.78

287

1620

Obesity due to excess calories

232

1534

1.52

8.42

1.1

1.3

2.14

1.98

mmol/l

0.85

215

1440

Diabetic neuropathy

267

2.29

8.36

1.3

1.2

2.30

2.44

mmol/l

0.38

251

Abnormal findings on diagnostic imaging of lung

199

1244

1.56

8.24

1.3

2.22

mmol/l

0.01

189

1150

Glomerular disorders in diseases classified elsewhere

296

2.21

8.23

1.1

1.4

2.09

2.06

mmol/l

0.10

280

Other heart diseases, wide

488

2267

1.34

8.18

1.3

2.09

2.03

mmol/l

0.41

452

2109

Other diseases of pleura

193

1090

1.57

8.14

1.3

2.20

mmol/l

0.00

178

1013

Selective deficiency of immunoglobulin G [IgG] subclasses

9.43

8.14

1.6

1.4

1.75

1.97

mmol/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

9.38

8.13

2.2

1.4

2.96

1.77

mmol/l

—

Other and unspecified spinal muscular atrophies

9.38

8.13

1.3

1.0

1.87

1.75

mmol/l

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

117

596

1.80

8.12

1.2

1.3

1.75

1.71

mmol/l

0.27

107

560

Superficial injury of head

108

594

1.83

8.05

1.1

1.3

2.00

2.03

mmol/l

0.07

556

Diabetes, varying definitions

516

2332

1.32

8.04

1.2

1.3

2.29

1.99

mmol/l

5.98

469

2167

Extracorporeal dialysis

142

2.78

7.98

1.3

1.2

2.04

2.00

mmol/l

0.10

135

Hypermobility syndrome

142

2.78

7.98

1.3

2.32

1.86

mmol/l

0.49

134

Nonorganic sleeping disorders

107

589

1.83

7.97

1.2

1.3

1.73

1.94

mmol/l

3.09

550

Noninfectious colitis NAS

366

2.06

7.97

1.3

2.16

2.04

mmol/l

0.36

345

Assault

393

2.02

7.97

1.2

1.3

1.85

1.93

mmol/l

0.44

370

Undetermined asthma, excluding more controls

274

2.24

7.97

1.3

1.2

2.17

1.98

mmol/l

0.54

260

Heart failure, not strict

337

1656

1.41

7.85

1.4

1.3

2.25

2.15

mmol/l

0.65

317

1540

Nephropathy related operations

322

2.13

7.83

1.3

2.45

1.97

mmol/l

1.17

302

Other diseases of upper respiratory tract

556

2218

1.31

7.80

1.2

1.3

1.93

2.12

mmol/l

4.11

509

2057

Sub-endpoint used in defining T1D endpoints

148

884

1.65

7.76

1.2

1.3

2.33

1.97

mmol/l

1.00

134

829

Dental caries 3

410

1533

1.37

7.75

1.3

2.03

2.11

mmol/l

0.72

387

1424

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

469

2151

1.33

7.73

1.2

1.3

2.38

2.02

mmol/l

4.01

428

1991

Undetermined asthma

278

2.20

7.71

1.3

1.2

2.17

1.99

mmol/l

0.51

262

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

157

960

1.62

7.68

1.5

1.2

1.77

1.88

mmol/l

1.13

143

897

Other respiratory disorders and diseases

489

1.89

7.66

1.4

1.2

2.22

2.13

mmol/l

0.31

457

Other diseases of the respiratory system

489

1.89

7.66

1.4

1.2

2.22

2.13

mmol/l

0.31

457

Gout

110

561

1.79

7.66

1.2

1.3

2.28

2.20

mmol/l

0.24

104

519

Dialysis, with operation codes

345

2.07

7.66

1.3

2.42

1.95

mmol/l

1.16

327

Striking against or struck by other objects

168

1057

1.59

7.65

1.2

1.3

1.82

1.98

mmol/l

1.69

153

991

Use of pramipexole

100

547

1.84

7.62

1.3

2.12

2.14

mmol/l

0.07

515

Diseases of male genital organs

258

881

1.48

7.56

1.2

1.98

2.13

mmol/l

1.23

239

815

Benign neoplasm of other and unspecified endocrine glands

340

2.07

7.56

1.2

1.3

2.11

2.12

mmol/l

0.00

317

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

485

1.89

7.54

1.2

1.3

1.85

1.90

mmol/l

0.30

459

Diseases of the digestive system

200

1313

1.52

7.48

1.3

2.10

2.12

mmol/l

0.07

179

1216

Dental caries 1, only avohilmo

393

1473

1.37

7.37

1.3

2.04

2.12

mmol/l

0.64

373

1367

Pain associated with micturition

297

2.14

7.36

1.5

1.3

1.96

2.04

mmol/l

0.28

279

Heart failure and antihypertensive medication

112

414

1.79

7.36

1.4

1.2

2.25

2.05

mmol/l

0.66

105

389

Type 2 diabetes

480

2164

1.32

7.32

1.2

1.3

2.35

2.02

mmol/l

3.60

435

2009

Unspecified haematuria

175

958

1.57

7.32

1.2

1.3

2.30

2.19

mmol/l

0.35

163

893

Parkinson's disease, strict definition

298

2.13

7.30

1.2

1.96

2.16

mmol/l

1.43

279

Acetic acid derivatives and related substances

141

434

1.70

7.29

1.2

2.04

2.16

mmol/l

0.42

129

401

Dental caries 1 and operation codes

421

1606

1.35

7.21

1.3

1.98

2.14

mmol/l

2.15

400

1488

Senile cataract

272

1174

1.44

7.15

1.3

2.30

2.22

mmol/l

0.43

258

1093

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

172

970

1.56

7.09

1.3

2.74

2.17

mmol/l

2.76

166

903

Covid-19 suspected case

115

672

1.72

7.04

1.2

1.82

1.90

mmol/l

0.76

109

624

Disorders of muscles

231

2.27

7.04

1.1

1.4

1.78

2.02

mmol/l

1.83

214

Unspecified/other endometriosis

270

2.16

7.02

1.2

1.60

1.89

mmol/l

3.34

249

Dental pulpitis 1, only avohilmo

564

2292

1.29

7.02

1.2

1.3

1.95

2.07

mmol/l

1.90

514

2138

Use of donepezil

316

2.05

7.02

1.2

1.96

2.19

mmol/l

1.41

290

Car occupant injured in other and unspecified transport accidents

103

584

1.77

7.02

1.2

1.3

1.98

1.92

mmol/l

0.22

545

Other abnormal uterine and vaginal bleeding

113

463

1.75

6.94

1.6

1.3

2.36

2.12

mmol/l

1.02

105

424

Injuries to the neck

121

720

1.69

6.94

1.2

1.3

1.76

1.97

mmol/l

3.00

109

676

Chronic lower respiratory diseases

621

2653

1.27

6.92

1.3

2.02

2.06

mmol/l

0.29

571

2465

Diabetes medication

507

2379

1.30

6.91

1.2

1.3

2.35

2.00

mmol/l

4.29

463

2212

Dentofacial anomalies [including malocclusion]

141

864

1.62

6.90

1.2

1.3

1.97

1.98

mmol/l

0.07

130

811

Sequelae of external causes of morbidity and mortality

114

669

1.71

6.88

1.6

1.3

2.25

2.10

mmol/l

0.56

108

626

Fenamates

282

1.95

6.88

1.6

1.2

2.23

2.14

mmol/l

0.27

265

Diabetic retinopathy

151

591

1.62

6.84

1.2

1.3

2.32

2.41

mmol/l

0.32

140

544

Dental caries 3, only avohilmo

411

1571

1.34

6.83

1.3

2.02

2.11

mmol/l

0.84

388

1460

Persistent mood disorders

510

1.81

6.77

1.2

1.3

2.21

1.97

mmol/l

0.60

478

Adverse effects, not elsewhere classified

104

598

1.75

6.77

1.3

1.4

1.75

1.97

mmol/l

3.01

561

Dental pulpitis 4, only avohilmo

560

2287

1.28

6.72

1.2

1.3

1.95

2.07

mmol/l

2.02

510

2133

Dental caries 3 and operation codes

438

1700

1.32

6.72

1.3

1.99

2.14

mmol/l

1.92

414

1577

Insulin, fast-acting (human)

426

1.89

6.69

1.1

1.3

2.16

1.91

mmol/l

1.79

399

Pulmonary heart disease, diseases of pulmonary circulation

131

804

1.63

6.67

1.5

1.3

2.23

2.12

mmol/l

0.55

123

748

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

136

843

1.62

6.67

1.3

1.86

2.02

mmol/l

1.73

122

788

Dental pulpitis 2

344

1286

1.37

6.66

1.3

1.98

2.12

mmol/l

1.58

324

1198

Diabetes, insulin treatment (Kela reimbursement)

481

2271

1.30

6.60

1.2

1.3

2.37

2.05

mmol/l

3.61

439

2102

Propionic acid derivatives

152

473

1.62

6.58

1.4

1.2

1.94

2.12

mmol/l

1.28

141

439

Other disorders of patella

515

1.79

6.57

1.2

1.4

1.97

1.94

mmol/l

0.12

479

Asthma, including avohilmo

591

2719

1.26

6.57

1.2

1.3

1.99

2.07

mmol/l

0.68

545

2525

Cutaneous abscess, furuncle and carbuncle

124

756

1.65

6.51

1.3

2.09

1.95

mmol/l

0.74

116

707

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

195

2.33

6.49

1.3

1.4

2.15

1.84

mmol/l

0.84

183

Myasthenia gravis

4.92

6.48

1.4

1.2

2.19

1.81

mmol/l

0.34

Venous thromboembolism

227

1533

1.44

6.48

1.4

1.3

2.33

2.17

mmol/l

0.84

211

1414

Urolithiasis

143

905

1.59

6.45

1.3

2.41

2.15

mmol/l

0.65

133

844

Diabetic nephropathy, excluding more controls

281

2.00

6.45

1.1

1.3

2.55

2.25

mmol/l

0.27

258

Asthma-related pneumonia or sepsis

156

1006

1.55

6.44

1.3

2.24

2.06

mmol/l

0.69

138

939

Asthma, hospital admissions 3, pneumonia

156

1006

1.55

6.44

1.3

2.24

2.06

mmol/l

0.69

138

939

Compression of brain

+∞

6.42

1.8

0.0

1.83

—

mmol/l

—

Other disorders of bone

101

587

1.73

6.36

1.2

1.3

1.94

2.03

mmol/l

0.34

552

Dental pulpitis 2, only avohilmo

351

1327

1.36

6.34

1.3

2.01

2.12

mmol/l

0.97

330

1235

Asthma-related pneumonia

155

1002

1.55

6.34

1.3

2.23

2.05

mmol/l

0.64

137

936

Other disorders of eyelid

177

1138

1.51

6.33

1.3

2.28

2.22

mmol/l

0.18

162

1052

DVT of lower extremities and pulmonary embolism

169

1112

1.52

6.31

1.4

1.3

2.31

2.13

mmol/l

1.04

157

1030

Benign neoplasm: Spinal cord

5.11

6.25

1.8

1.2

2.58

1.72

mmol/l

1.34

Pulmonary heart disease

121

741

1.64

6.25

1.5

1.3

2.26

2.12

mmol/l

0.64

113

694

Voice disturbances

119

727

1.64

6.22

1.2

1.3

2.02

2.04

mmol/l

0.05

114

680

Obesity and other hyperalimentation

291

2109

1.37

6.20

1.1

1.3

2.13

2.01

mmol/l

0.62

270

1966

Meniscus derangement

258

1256

1.41

6.19

1.2

1.3

2.00

2.14

mmol/l

1.79

236

1164

Pulmonary embolism

121

743

1.63

6.19

1.5

1.3

2.26

2.12

mmol/l

0.63

113

696

Asthma (diagnoses ohter than nonallergic)

415

2732

1.30

6.16

1.3

1.2

2.04

mmol/l

0.00

382

2541

Diseases of external ear

149

963

1.55

6.15

1.2

1.3

1.96

2.05

mmol/l

0.44

139

903

Dental operations

302

1124

1.38

6.14

1.3

1.96

2.18

mmol/l

3.18

286

1041

Other predominantly sexually transmitted diseases, not elsewhere classified

571

1.72

6.13

1.2

1.3

1.87

1.90

mmol/l

0.19

529

Carpal tunnel syndrome

259

1680

1.39

6.12

1.2

1.3

2.10

2.13

mmol/l

0.16

245

1552

Gastroduodenal ulcer

104

615

1.69

6.10

1.3

2.21

2.19

mmol/l

0.06

571

Hyperplasia of prostate

157

575

1.56

6.07

1.2

2.03

2.19

mmol/l

1.10

145

532

Alzheimer disease

426

1.74

6.06

1.1

1.2

2.00

2.22

mmol/l

2.18

385

Paracetamol of NSAID medication

259

1.81

6.04

1.3

1.2

1.87

2.05

mmol/l

0.95

241

Superficial injury of wrist and hand

101

596

1.70

6.04

1.1

1.3

1.76

1.95

mmol/l

1.62

558

Acute and transient psychotic disorders

349

1.93

6.04

1.2

1.3

2.06

1.99

mmol/l

0.13

328

Open wound of wrist and hand

209

1439

1.44

6.03

1.2

1.3

1.94

2.03

mmol/l

0.67

187

1346

Lateral epicondylitis

329

1.96

5.99

1.3

1.5

1.87

2.12

mmol/l

2.20

307

Mouth breathing

185

1258

1.47

5.99

1.2

1.3

1.89

2.07

mmol/l

2.48

172

1182

Obesity

288

2099

1.36

5.97

1.1

1.3

2.13

2.02

mmol/l

0.64

267

1957

Benign neoplasm: Colon

196

1028

1.46

5.93

1.2

1.3

2.10

2.15

mmol/l

0.27

180

957

Oter anti-inflammatory and antirheumatic agents, non-steroids

108

352

1.71

5.89

1.2

2.12

2.25

mmol/l

0.52

325

Other arrhythmias

301

1704

1.36

5.85

1.2

1.3

2.01

2.07

mmol/l

0.48

269

1590

Calculus of kidney and ureter

131

833

1.58

5.84

1.3

2.46

2.14

mmol/l

0.79

122

776

Conjunctivitis (acute, non atopic)

139

893

1.56

5.84

1.2

1.3

1.95

1.97

mmol/l

0.06

133

833

Benign neoplasm: Colon, unspecified

539

1.72

5.84

1.2

1.3

2.27

2.16

mmol/l

0.33

504

Pruritus

258

2.07

5.79

1.2

1.3

2.06

mmol/l

0.02

244

Use of disulfiram, acamprosate or naltrexone

245

2.10

5.77

1.1

1.4

2.31

1.95

mmol/l

0.73

233

Other enthesopathies

134

859

1.56

5.77

1.3

1.94

2.12

mmol/l

2.16

125

804

Inflammatory diseases of prostate (prostatitis)

306

1.97

5.76

1.4

1.2

1.98

2.16

mmol/l

0.88

287

Reimbursement for rheumatic diseases

258

1874

1.38

5.75

1.3

2.32

2.08

mmol/l

0.97

242

1737

Fentanyl

193

2.24

5.74

1.2

2.57

2.03

mmol/l

1.58

179

TMD related operations

478

1.77

5.74

1.3

1.4

1.99

1.97

mmol/l

0.07

446

Fracture of lumbar spine and pelvis

507

1.74

5.72

1.2

1.3

2.03

2.08

mmol/l

0.17

469

Alzheimer disease, including avohilmo

113

497

1.65

5.70

1.2

2.16

2.24

mmol/l

0.25

105

447

Methotrexate

386

1.85

5.64

1.1

1.4

2.67

2.00

mmol/l

0.80

362

Deviated nasal septum

150

992

1.52

5.60

1.3

1.98

2.15

mmol/l

1.32

140

931

Enthesopathies of lower limb, excluding foot

587

1.68

5.58

1.3

1.84

2.10

mmol/l

3.06

553

Other and unspecified mood [affective] disorders

171

2.30

5.53

1.1

1.3

2.32

1.83

mmol/l

0.55

162

Sequelae of injuries, of poisoning and of other consequences of external causes

112

697

1.61

5.49

1.4

1.3

1.89

2.01

mmol/l

0.63

655

Superficial injury of thorax

405

1.81

5.45

1.2

1.3

2.09

2.02

mmol/l

0.12

378

Rotator cuff syndrome

265

1444

1.37

5.43

1.2

1.3

1.94

2.24

mmol/l

6.60

247

1343

Deforming dorsopathies

120

763

1.58

5.39

1.2

1.3

1.95

2.05

mmol/l

0.78

107

716

Chronic diseases of tonsils and adenoids

391

1916

1.29

5.38

1.2

1.3

1.88

2.07

mmol/l

2.79

356

1785

Tinnitus

102

625

1.64

5.34

1.2

1.3

1.89

2.11

mmol/l

1.94

593

Disorders of male genital organs in diseases classified elsewhere

11.65

5.34

1.2

1.1

1.73

1.67

mmol/l

—

Fracture of skull and facial bones

587

1.66

5.33

1.4

1.2

2.07

2.01

mmol/l

0.23

554

Acute suppurative otitis media

144

892

1.51

5.30

1.3

1.95

1.84

mmol/l

0.45

134

825

Fracture of foot, except ankle

116

735

1.58

5.30

1.3

1.99

1.95

mmol/l

0.17

104

690

Benign neoplasm of colon, rectum, anus and anal canal

221

1128

1.40

5.29

1.2

1.3

2.06

2.13

mmol/l

0.48

204

1052

Allergic asthma (mode), excluding more controls

101

607

1.64

5.28

1.4

1.2

1.79

1.90

mmol/l

0.74

570

Wegener granulomatosis

4.69

5.28

1.0

1.2

2.01

2.00

mmol/l

0.02

Papulosquamous disorders

171

1178

1.46

5.27

1.2

1.3

2.08

2.07

mmol/l

0.03

156

1098

Gout, FINNGEN

110

690

1.60

5.24

1.2

2.28

2.23

mmol/l

0.15

104

640

Diseases of peritoneum

248

2.03

5.23

1.4

1.3

2.11

2.09

mmol/l

0.04

233

Personal history of certain other diseases

3.69

5.23

1.5

1.6

1.95

1.69

mmol/l

0.62

Allergic asthma (mode)

101

609

1.63

5.22

1.4

1.2

1.79

1.91

mmol/l

0.81

572

Iridocyclitis

105

655

1.61

5.13

1.2

1.3

2.14

2.04

mmol/l

0.42

615

Keratitis

159

1086

1.47

5.13

1.3

2.04

2.03

mmol/l

0.03

149

1017

Other diseases of anus and rectum

124

805

1.54

5.08

1.3

2.13

2.14

mmol/l

0.03

114

750

Additional codes for the location of defect, injury or illness

134

2.41

5.06

1.2

1.4

1.65

1.96

mmol/l

2.79

126

Occlusion and stenosis of arteries, not leading to stroke

10.14

5.04

1.9

1.1

2.46

1.97

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

475

1.71

5.04

1.1

1.3

1.74

1.94

mmol/l

2.11

444

Corneal ulcer

536

1.67

5.01

1.3

2.08

2.01

mmol/l

0.18

501

Other gastritis (incl. Duodenitis)

583

1.64

4.97

1.2

1.3

2.04

2.11

mmol/l

0.21

549

Congenital malformations, deformations and chromosomal abnormalities

287

2083

1.32

4.96

1.4

1.2

2.03

1.94

mmol/l

0.72

268

1938

Diseases of oral cavity, salivary glands and jaws

439

1782

1.27

4.94

1.3

1.99

2.07

mmol/l

0.89

410

1653

Dislocation, sprain and strain of joints and ligaments of knee

291

2055

1.32

4.90

1.2

1.3

1.87

2.04

mmol/l

2.98

274

1902

Abnormal blood-pressure reading, without diagnosis

106

2.57

4.89

1.2

1.88

2.05

mmol/l

0.70

Crohn's disease of small intestine

194

2.13

4.88

1.3

2.03

1.96

mmol/l

0.13

184

Early onset COPD, excluding more controls

442

1.72

4.86

1.4

1.2

2.16

2.17

mmol/l

0.05

415

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

362

1.80

4.84

1.2

2.49

2.11

mmol/l

1.02

337

Disorders of phosphorus metabolism and phosphatases

11.92

4.83

1.3

1.0

2.01

1.78

mmol/l

—

Convergence insufficiency and excess

4.66

4.80

1.5

1.2

2.05

1.71

mmol/l

0.75

Anterior Iridocyclitis

597

1.61

4.79

1.2

1.3

2.19

2.03

mmol/l

0.68

560

Other diseases of the digestive system

125

826

1.52

4.77

1.3

2.20

2.13

mmol/l

0.34

111

771

Suppurative and unspecified otitis media

187

1182

1.41

4.74

1.3

1.2

1.92

1.87

mmol/l

0.21

174

1100

Trigeminal neuralgia

120

2.43

4.72

1.3

2.00

1.88

mmol/l

0.32

112

Cervicocranial syndrome

252

1.95

4.67

1.2

1.3

1.88

2.08

mmol/l

0.74

241

Gastric ulcer

412

1.73

4.61

1.4

1.3

2.17

2.16

mmol/l

0.05

385

Vasomotor and allergic rhinitis

178

1250

1.41

4.60

1.2

1.3

1.85

1.98

mmol/l

0.98

166

1172

Hand

10.37

4.56

1.1

1.3

1.74

1.66

mmol/l

—

Rheumatoid arthritis

131

802

1.49

4.53

1.2

1.3

2.21

2.14

mmol/l

0.33

117

743

Gout, idiopatic and unspecified

575

1.61

4.52

1.2

2.33

2.20

mmol/l

0.38

539

Diseases of arteries, arterioles and capillaries

262

1478

1.32

4.49

1.3

2.27

2.17

mmol/l

0.77

241

1370

Acute and subacute iridocyclitis

553

1.62

4.48

1.2

1.3

2.22

2.04

mmol/l

0.75

519

Soft tissue disorders related to use, overuse and pressure

109

710

1.54

4.48

1.3

2.27

2.17

mmol/l

0.14

664

Orthopaedic devices associated with adverse incidents

4.07

4.45

1.3

1.1

1.98

1.90

mmol/l

0.29

Other (seronegative) rheumatoid arthritis, wide

493

1.65

4.43

1.2

1.4

2.29

2.10

mmol/l

0.69

465

5-aminosalicylic acid

625

1.57

4.43

1.3

1.96

mmol/l

0.03

586

Injuries to the hip and thigh

183

1207

1.39

4.41

1.3

2.13

2.11

mmol/l

0.06

165

1124

Other (not insulin) diabetes medications

431

2090

1.24

4.39

1.2

1.3

2.37

2.05

mmol/l

2.95

394

1941

Unspecified misadventure during surgical and medical care

131

2.31

4.37

1.4

2.26

2.02

mmol/l

0.47

123

Disorders of gallbladder, biliary tract and pancreas

444

2315

1.24

4.34

1.2

1.3

2.14

2.10

mmol/l

0.24

420

2139

Lagophthalmos

4.63

4.32

1.3

1.2

3.21

1.88

mmol/l

—

Other and unspecified disorders of binocular movement

9.19

4.32

1.1

1.3

1.69

1.67

mmol/l

—

Impingement syndrome of shoulder

105

685

1.54

4.30

1.4

2.16

2.21

mmol/l

0.20

642

Disorders of vitreous body and globe

196

1402

1.37

4.29

1.2

1.3

2.11

2.25

mmol/l

1.24

182

1302

Dental pulpitis 3

317

1.69

4.20

1.3

1.2

1.65

1.67

mmol/l

0.09

296

Inflammatory bowel disease

147

1032

1.43

4.19

1.3

1.96

1.97

mmol/l

0.04

140

964

Ulcer of lower limb, not elsewhere classified

313

1.80

4.17

1.2

1.3

2.59

2.11

mmol/l

1.09

294

Benign neoplasm: Colon, unspecified

595

1.57

4.17

1.2

1.3

2.27

2.17

mmol/l

0.32

560

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

430

2269

1.24

4.17

1.2

1.3

2.16

2.11

mmol/l

0.28

404

2097

Biguanides

426

2124

1.24

4.16

1.2

1.3

2.34

2.06

mmol/l

2.57

388

1972

Seborrhoeic dermatitis

235

1.93

4.15

1.8

1.3

2.05

2.02

mmol/l

0.10

221

Cholecystectomy

298

2058

1.28

4.14

1.2

1.3

2.17

2.14

mmol/l

0.15

284

1892

Burns and corrosions

388

1.71

4.14

1.1

1.3

2.15

1.99

mmol/l

0.55

362

Glucosamine medication

185

1075

1.38

4.14

1.3

2.35

2.28

mmol/l

0.18

171

990

Dental operations, only avohilmo

317

1265

1.29

4.13

1.3

1.2

2.01

2.17

mmol/l

1.67

301

1175

Dental pulpitis 3, only avohilmo

296

1.71

4.12

1.2

1.63

1.66

mmol/l

0.16

276

Other and unspecified injuries of head

141

2.21

4.12

1.2

1.4

2.13

1.99

mmol/l

0.20

132

Fall on same level involving ice and snow

241

1837

1.31

4.11

1.2

1.3

2.07

2.08

mmol/l

0.04

218

1709

Disorders of conjunctiva

379

2552

1.25

4.10

1.2

1.3

1.92

2.04

mmol/l

1.45

349

2369

Aspergillosis

8.20

4.09

1.3

1.1

1.99

1.76

mmol/l

—

Cholecystitis

330

1.76

4.08

1.2

1.3

2.12

2.16

mmol/l

0.12

304

Childhood asthma (age<16)

271

1.76

4.06

1.3

1.2

1.85

1.77

mmol/l

0.23

257

Childhood asthma (age<16), excluding more controls

271

1.76

4.05

1.3

1.2

1.85

1.77

mmol/l

0.24

257

Congenital hydrocephalus

10.41

4.05

1.3

1.75

1.55

mmol/l

—

Benign neoplasm: Colon

198

1440

1.35

4.03

1.2

1.3

2.10

2.24

mmol/l

1.01

181

1333

Colonic or urogenital fistula

117

794

1.48

4.01

1.2

1.3

2.07

2.09

mmol/l

0.03

107

749

Acute laryngitis and tracheitis

334

1.75

4.00

1.1

1.3

1.97

1.83

mmol/l

0.54

314

Viral and other specified intestinal infections

101

649

1.52

4.00

1.4

1.2

1.92

1.86

mmol/l

0.31

607

Endometriosis

165

700

1.41

4.00

1.3

1.2

2.07

2.01

mmol/l

0.18

154

647

Drug-induced osteoporosis with pathological fracture

3.99

1.2

1.1

2.04

1.90

mmol/l

0.25

Sequelae of other and unspecified infectious and parasitic diseases

150

2.15

3.96

1.8

1.4

2.81

1.95

mmol/l

0.99

142

Bacterial pneumoniae

156

988

1.40

3.95

1.4

1.3

2.12

2.05

mmol/l

0.25

133

923

Thyrotoxicosis, other and/or unspecified

540

1.58

3.95

1.5

1.3

2.20

2.02

mmol/l

0.70

506

Haemorrhage from respiratory passages

134

867

1.44

3.95

1.2

1.3

2.14

2.19

mmol/l

0.19

127

804

Alzheimer’s disease, wide definition

352

1.67

3.94

1.1

1.2

1.95

2.23

mmol/l

2.72

320

Other and unspecified psoriasis

157

2.12

3.94

1.2

1.4

1.88

2.04

mmol/l

0.65

147

Dyshidrosis [pompholyx]

3.69

3.94

1.6

1.2

1.94

mmol/l

0.01

Persistent delusional disorders

178

2.03

3.89

1.1

1.3

2.41

2.02

mmol/l

0.41

167

Fissure and fistula of anal and rectal regions

106

710

1.50

3.88

1.2

1.3

2.01

2.08

mmol/l

0.17

670

Disorders of vitreous body

189

1374

1.35

3.86

1.2

1.3

2.08

2.25

mmol/l

1.79

175

1275

Orchitis and epididymitis

206

1.95

3.86

1.4

1.3

2.19

2.06

mmol/l

0.26

194

L04AD Calcineurin inhibitors

292

1.79

3.85

1.3

1.4

2.35

1.97

mmol/l

0.61

273

Amenorrhoea

200

1.96

3.82

1.1

1.3

1.81

1.86

mmol/l

0.15

185

Other fall from one level to another

104

697

1.50

3.80

2.0

1.2

2.11

1.96

mmol/l

0.67

649

Otitis externa

649

1.52

3.80

1.1

1.3

1.98

2.02

mmol/l

0.10

608

Dyslexia and other symbolic dysfunctions, not elsewhere classified

12.44

3.79

1.2

1.6

1.98

1.89

mmol/l

—

Dermatophytosis

338

1.72

3.79

1.5

1.3

3.11

2.03

mmol/l

0.95

318

Superficial injury of forearm

265

1.82

3.77

1.3

1.4

2.14

1.93

mmol/l

0.34

247

Other diseases of lip and oral mucosa

430

1.63

3.76

1.4

2.01

2.12

mmol/l

0.29

406

Diabetic nephropathy

402

1.65

3.74

1.1

1.2

2.55

2.39

mmol/l

0.13

372

Disorders of synovium and tendon

224

1542

1.31

3.73

1.2

1.3

1.92

2.16

mmol/l

3.37

210

1431

Chronic gastritis

103

692

1.49

3.73

1.1

1.3

2.13

2.16

mmol/l

0.08

643

Other disorders of thyroid

4.06

3.71

1.5

1.2

2.29

1.96

mmol/l

—

Other obstetric conditions, not elsewhere classified

167

789

1.38

3.70

1.3

1.2

1.77

1.76

mmol/l

0.02

157

735

Bacterial pneumonia, not elsewhere classified

146

926

1.40

3.69

1.4

1.3

2.04

2.05

mmol/l

0.04

125

866

Assault by bodily force

224

1.89

3.68

1.2

1.4

1.85

1.88

mmol/l

0.13

210

Bacterial pneumonia (organism specified)

173

1163

1.36

3.67

1.4

1.3

2.29

2.09

mmol/l

0.53

150

1083

Phlebitis and thrombophlebitis (not including DVT)

607

1.52

3.65

1.2

1.3

2.33

2.05

mmol/l

0.94

573

Agoraphobia

2.63

3.65

1.2

1.91

1.84

mmol/l

0.15

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

164

775

1.38

3.62

1.4

1.2

1.77

1.76

mmol/l

0.07

154

723

Anti-inflammatory and antirheumatic products, non-steroids

135

473

1.44

3.62

1.4

1.2

1.96

2.12

mmol/l

0.82

125

439

GI-bleeding

118

821

1.44

3.59

1.4

1.3

2.24

2.17

mmol/l

0.28

104

764

Other/unspecified rheumatoid arthritis

299

1.75

3.58

1.3

2.39

2.18

mmol/l

0.63

279

Infective dermatitis

292

1.75

3.56

1.2

1.3

2.06

mmol/l

0.02

274

Thyrotoxicosis

104

708

1.47

3.56

1.5

1.3

2.17

2.04

mmol/l

0.58

662

Tonsillectomy and adenotomy

283

1557

1.27

3.55

1.2

1.3

1.79

1.89

mmol/l

1.04

257

1456

Nonsuppurative otitis media

114

681

1.45

3.53

1.1

1.3

2.23

1.84

mmol/l

1.28

109

630

Type 2 diabetes, definitions combined

414

2031

1.22

3.53

1.2

1.3

2.32

2.04

mmol/l

4.20

377

1886

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

127

901

1.41

3.49

1.3

2.07

1.96

mmol/l

0.31

122

844

Spontaneous abortion

201

1035

1.32

3.48

1.2

1.95

2.02

mmol/l

0.34

188

961

Fall on and from stairs and steps

106

728

1.46

3.48

1.3

2.09

2.06

mmol/l

0.10

685

Other abnormal products of conception

147

706

1.39

3.47

1.3

1.2

1.80

1.93

mmol/l

1.47

139

658

Arthrosis

314

1378

1.25

3.47

1.2

1.3

2.03

2.12

mmol/l

0.83

292

1271

Glucagon-like peptide-1 (GLP-1) analogues

207

1301

1.31

3.46

1.2

1.3

2.52

2.13

mmol/l

3.42

186

1208

Oxicams

102

389

1.49

3.43

1.1

1.2

1.95

2.21

mmol/l

1.95

360

Open wound of ankle and foot

274

1.76

3.41

1.3

1.4

1.79

1.94

mmol/l

0.88

257

Type 2 diabetes, strict (exclude DM1)

416

2051

1.21

3.40

1.2

1.3

2.32

2.04

mmol/l

4.07

379

1905

Localized swelling, mass and lump of skin and subcutaneous tissue

123

873

1.41

3.39

1.3

2.03

2.07

mmol/l

0.15

113

816

Narcolepsy and cataplexy

7.15

3.38

1.1

1.6

1.91

1.73

mmol/l

—

Paroxysmal tachycardia

500

1.51

3.36

1.2

2.08

1.91

mmol/l

0.64

463

Noninflammatory disorders of female genital tract

208

795

1.32

3.35

1.2

1.91

1.96

mmol/l

0.29

195

737

Atrial fibrillation and flutter with reimbursement

402

1.50

3.33

1.1

1.2

2.41

1.96

mmol/l

1.33

374

Type 2 diabetes, definitions combined, including avohilmo

418

2050

1.21

3.31

1.3

2.33

2.04

mmol/l

4.36

380

1904

Ovarian cyst

171

736

1.35

3.26

1.2

1.81

1.99

mmol/l

2.84

160

680

Atopic dermatitis

256

1734

1.26

3.21

1.2

1.86

1.94

mmol/l

0.63

242

1621

IBD patients in KELA-register

107

750

1.43

3.19

1.3

1.93

1.96

mmol/l

0.09

102

701

Injuries to the elbow and forearm

295

2156

1.24

3.17

1.2

1.3

2.08

2.05

mmol/l

0.16

267

2005

Anorexia (incl.atypical)

158

1.97

3.14

1.1

1.4

1.92

1.79

mmol/l

0.49

149

Gonarthrosis [arthrosis of knee](FG)

318

1518

1.23

3.14

1.3

2.12

2.15

mmol/l

0.23

290

1411

Chondropathies

452

1.55

3.12

1.3

1.88

2.01

mmol/l

0.82

424

Obsessive-compulsive disorder

166

1.94

3.09

1.1

1.2

1.68

1.82

mmol/l

0.58

155

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

256

1667

1.25

3.08

1.3

1.2

2.06

2.01

mmol/l

0.22

244

1548

Other disorders of peripheral nervous system

7.67

3.07

1.0

1.4

1.97

2.00

mmol/l

—

Maternal care for other conditions predominantly related to pregnancy

681

1.44

3.05

1.1

1.3

1.90

1.86

mmol/l

0.12

636

Disorders of pituitary gland, other and/or unspecified

5.99

3.04

1.4

1.1

2.16

1.76

mmol/l

—

Other disorders of the musculoskeletal system and connective tissue

384

1.59

3.04

1.5

1.3

2.14

2.09

mmol/l

0.12

357

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

201

1062

1.29

3.03

1.2

1.3

2.23

2.17

mmol/l

0.24

183

988

Generalized epilepsy, strict definition

2.92

3.03

1.4

1.2

1.79

1.74

mmol/l

0.07

Other cataract

163

952

1.33

3.01

1.3

2.15

2.24

mmol/l

0.44

153

882

Cervicobrachial syndrome

577

1.48

3.01

1.6

1.3

1.96

2.06

mmol/l

0.56

542

Cushing syndrome

4.36

3.01

1.3

1.81

1.98

mmol/l

—

Metabolic disorder, other/unspecified

10.39

3.01

1.0

1.8

1.58

1.44

mmol/l

—

Presbycusis

232

1.76

2.98

1.1

1.2

2.08

2.15

mmol/l

0.30

211

Spondyloarthritis

506

1.51

2.96

1.3

2.16

1.96

mmol/l

0.70

474

Spondylolisthesis/Spondylolysis

442

1.54

2.96

1.1

1.3

1.95

2.12

mmol/l

1.13

418

Trochanteric bursitis

317

1.65

2.95

1.3

1.4

1.97

2.14

mmol/l

1.14

296

4.78

2.93

1.1

1.80

1.68

mmol/l

—

Atrial fibrillation and flutter

116

542

1.40

2.91

1.1

1.2

2.29

1.95

mmol/l

1.16

105

508

Endometriosis of pelvic peritoneum

478

1.51

2.90

1.1

1.2

1.81

2.01

mmol/l

0.94

440

Hyperosmolality and hypernatraemia

4.15

2.89

1.1

2.29

1.93

mmol/l

—

Postzoster neuralgia

4.15

2.89

1.2

1.1

3.21

1.87

mmol/l

—

Postdysenteric arthropathy

5.47

2.88

1.1

1.3

5.59

1.72

mmol/l

—

Fibroblastic disorders

583

1.46

2.87

1.2

1.3

2.17

2.29

mmol/l

0.40

549

Inflammatory bowel disease, strict (require KELA)

107

766

1.40

2.87

1.3

1.93

1.96

mmol/l

0.10

102

715

Conjunctivitis

336

2427

1.21

2.87

1.3

1.93

2.02

mmol/l

0.86

311

2258

Benign lipomatous neoplasm

109

783

1.40

2.86

1.2

1.3

2.29

2.07

mmol/l

0.66

100

736

Excessive attrition of teeth

190

795

1.30

2.86

1.2

1.3

1.94

2.01

mmol/l

0.47

174

738

Benign neoplasm of colon, rectum, anus and anal canal

229

1652

1.25

2.79

1.2

1.3

2.05

2.22

mmol/l

1.63

209

1535

Infection of intervertebral disc (pyogenic)

3.97

2.79

1.3

1.1

2.23

1.88

mmol/l

—

Hypertensive encephalopathy

8.61

2.77

1.4

1.0

1.84

1.87

mmol/l

—

Retinal detachments and breaks

123

907

1.36

2.77

1.3

2.24

2.19

mmol/l

0.12

114

841

Other/unspecified mastoiditis and related conditions

8.54

2.76

1.0

1.2

4.84

1.85

mmol/l

—

Flatulence and related conditions

5.07

2.74

1.0

1.1

1.90

1.61

mmol/l

—

Open wound of forearm

240

1.72

2.73

1.3

1.4

1.91

1.99

mmol/l

0.27

224

Lupus erythematosus

2.73

2.72

1.2

1.3

1.78

1.96

mmol/l

0.69

Artificial joint operation, meniscal resection

373

2082

1.19

2.72

1.3

2.13

2.16

mmol/l

0.12

341

1936

Asthma, hospital admissions , main diagnosis only

365

2747

1.19

2.71

1.3

1.98

2.05

mmol/l

0.57

331

2554

Postprocedural musculoskeletal disorders, not elsewhere classified

160

1.89

2.71

1.6

1.2

2.42

2.15

mmol/l

0.42

149

Shock, not elsewhere classified

6.08

2.71

1.0

1.67

1.75

mmol/l

—

Preparation and fitting of bite rail to mouth

404

1.54

2.71

1.2

1.4

2.10

2.01

mmol/l

0.26

377

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

691

1.41

2.70

1.3

2.47

2.00

mmol/l

2.02

658

Failed induction of labour

182

1.82

2.69

1.2

1.3

1.67

1.71

mmol/l

0.20

168

Foreign body in genitourinary tract

4.28

2.69

1.1

1.4

1.78

1.94

mmol/l

—

Cholelithiasis, broad definition with cholecystitis

366

2104

1.19

2.69

1.2

1.3

2.16

2.11

mmol/l

0.33

346

1941

Injury of nerves at shoulder and upper arm level

3.81

2.69

1.2

1.3

1.81

2.01

mmol/l

—

Disorder of thyroid, unspecified

3.80

2.68

1.1

1.3

2.04

1.98

mmol/l

—

Other specified and unspecified personality disorders

280

1.65

2.67

1.2

1.4

1.95

1.98

mmol/l

0.06

263

Ganglion

594

1.43

2.64

1.3

1.4

1.86

2.05

mmol/l

2.28

554

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

2.56

2.62

1.4

1.3

3.36

1.94

mmol/l

0.42

Thyroiditis, ILD-related definition

297

1.62

2.61

1.5

1.4

2.03

1.97

mmol/l

0.21

278

Folate deficiency anaemia

4.75

2.61

1.0

1.1

1.89

1.85

mmol/l

—

Other eating disorders

141

1.93

2.60

1.1

1.3

1.52

1.75

mmol/l

3.52

132

Phobic anxiety disorders

368

1.55

2.60

1.2

1.3

1.81

1.89

mmol/l

0.44

342

Other overlap syndromes

2.93

2.59

1.8

1.3

1.80

1.96

mmol/l

0.81

Seronegative rheumatoid arthritis

275

1.64

2.58

1.2

1.5

2.36

2.05

mmol/l

0.76

263

7.33

2.56

1.4

1.3

1.66

1.70

mmol/l

—

Disorders of other and unspecified cranial nerves

5.59

2.56

1.5

1.2

1.59

1.84

mmol/l

—

Malignant neoplasm of nasal cavity and sinuses

5.57

2.56

1.0

1.1

4.20

1.77

mmol/l

—

Valgus deformity, not elsewhere classified

5.54

2.55

1.0

1.6

1.61

1.62

mmol/l

—

Allergic urticaria

215

1.73

2.55

1.2

1.3

1.87

1.92

mmol/l

0.20

201

Diverticular disease of intestine

270

1469

1.22

2.55

1.2

1.3

2.19

2.20

mmol/l

0.06

247

1363

Palmar fascial fibromatosis [Dupuytren]

354

1.56

2.55

1.1

1.2

2.29

2.35

mmol/l

0.13

332

Coxarthrosis

184

980

1.28

2.54

1.2

1.3

2.20

2.19

mmol/l

0.03

168

902

Statin medication

325

1520

1.20

2.50

1.4

1.3

2.11

2.08

mmol/l

0.20

301

1414

Other acute viral hepatitis

3.51

2.49

1.0

1.3

1.81

1.77

mmol/l

—

Rheumatoid arthritis, including avohilmo

147

1133

1.30

2.48

1.2

1.3

2.22

2.06

mmol/l

0.93

133

1056

Other benign neoplasms of skin

132

983

1.32

2.48

1.2

1.3

2.08

2.12

mmol/l

0.15

122

913

Lichen planus

310

1.59

2.46

1.4

1.2

2.08

2.07

mmol/l

0.02

289

Myocardial infarction, strict

109

1068

0.74

2.44

1.2

1.3

2.35

2.17

mmol/l

0.61

999

Pregnancy with abortive outcome

283

1220

1.21

2.43

1.4

1.2

1.91

2.04

mmol/l

1.52

260

1126

Iridocyclitis in diseases classified elsewhere

2.97

2.42

1.3

1.2

1.99

1.86

mmol/l

—

Benign neoplasm: Brain, unspecified

5.11

2.42

1.3

1.4

2.32

1.86

mmol/l

—

Atopic dermatitis, strict definition with reimbursement

137

1020

1.30

2.38

1.2

1.3

1.85

1.87

mmol/l

0.09

130

959

Gonarthrosis

262

1235

1.22

2.37

1.2

1.3

2.10

2.15

mmol/l

0.33

241

1145

Dermatographic urticaria

168

1.79

2.36

1.3

1.4

1.67

1.91

mmol/l

2.15

157

Redundant prepuce, phimosis and paraphimosis

556

1.42

2.34

1.3

2.06

2.04

mmol/l

0.07

520

Psoriasis

114

857

1.33

2.33

1.2

1.3

2.07

2.05

mmol/l

0.06

105

805

Other disorders of optic disc

3.26

2.32

1.7

1.2

1.76

1.92

mmol/l

—

Follicular cysts of skin and subcutaneous tissue

519

1.43

2.30

1.3

2.08

2.05

mmol/l

0.08

486

DVT of lower extremities

470

1.45

2.29

1.2

1.4

2.32

2.08

mmol/l

0.71

441

Medical abortion

268

1204

1.21

2.29

1.4

1.2

1.99

2.05

mmol/l

0.37

244

1113

Androgenic alopecia

4.69

2.28

1.7

1.2

2.02

1.86

mmol/l

—

Severe visual impairment, monocular

4.68

2.28

1.7

1.2

3.57

1.84

mmol/l

—

Chronic hepatitis NAS

3.52

2.28

1.3

2.01

1.85

mmol/l

—

Benign neoplasm: Other/unspecified site

3.51

2.27

1.3

1.2

1.95

1.96

mmol/l

—

Coxarthrosis [arthrosis of hip](FG)

195

1134

1.25

2.27

1.2

1.3

2.28

2.19

mmol/l

0.25

176

1050

Kidney transplant status

134

1.88

2.27

1.2

1.3

1.88

1.99

mmol/l

0.33

127

Use of memantine

395

1.46

2.24

1.2

1.97

2.23

mmol/l

2.38

355

Use of other anti-dementia drugs

395

1.46

2.24

1.2

1.97

2.23

mmol/l

2.38

355

Allergic rhinitis

140

1079

1.29

2.23

1.3

1.79

1.90

mmol/l

1.09

132

1004

Hypothyroidism, autoimmune, DX-based

5.71

2.23

1.2

1.7

1.93

1.94

mmol/l

—

Other maternal disorders predominantly related to pregnancy

251

1303

1.21

2.23

1.3

1.89

2.02

mmol/l

1.99

237

1208

Toxic effect of organic solvents

5.71

2.23

1.0

1.4

2.44

2.07

mmol/l

—

Other disorders of conjunctiva

351

1.51

2.21

1.1

1.3

1.80

2.15

mmol/l

3.21

326

Other acquired deformities of musculoskeletal system and connective tissue

114

1.94

2.20

1.5

1.3

1.91

2.01

mmol/l

0.27

109

Retinal haemorrhage

2.80

2.20

1.8

1.2

2.06

1.92

mmol/l

—

Hallux valgus (acquired)

127

704

1.31

2.19

1.2

1.3

2.31

2.12

mmol/l

0.61

114

652

Gingivitis and periodontal diseases

398

1765

1.17

2.18

1.2

1.3

1.93

2.08

mmol/l

2.86

369

1638

Disorders of breast

197

1483

1.23

2.18

1.2

1.3

1.97

2.08

mmol/l

0.79

181

1371

Benign neoplasm: Brain, unspecified

4.37

2.16

1.3

1.4

2.32

1.90

mmol/l

—

Benign neoplasm of urinary organs

2.03

2.16

1.2

1.71

1.99

mmol/l

1.27

Urticaria due to cold and heat

4.35

2.16

1.0

1.4

1.68

1.89

mmol/l

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

4.34

2.16

1.0

1.1

4.20

1.72

mmol/l

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

3.72

2.16

1.3

1.2

2.96

2.06

mmol/l

—

Hernia

403

2362

1.16

2.14

1.2

1.3

2.12

2.11

mmol/l

0.09

371

2186

Female genital prolapse

121

531

1.32

2.14

1.2

2.06

2.11

mmol/l

0.24

110

487

Fracture at wrist and hand level

137

1070

1.28

2.14

1.2

1.3

1.88

2.01

mmol/l

0.98

127

1009

Benign neoplasm of urinary organs

2.01

2.10

1.2

1.71

2.03

mmol/l

1.46

Drug-induced hypoglycaemia without coma

3.23

2.10

1.1

1.2

1.95

1.87

mmol/l

—

Cholelithiasis

344

2065

1.17

2.09

1.2

1.3

2.15

2.11

mmol/l

0.27

324

1903

Moderate visual impairment, monocular

5.14

2.09

1.8

1.3

1.98

1.71

mmol/l

—

Acne conglobata

5.09

2.08

1.8

1.3

1.96

1.72

mmol/l

—

Haemorrhage in early pregnancy

120

903

1.30

2.08

1.2

1.3

1.86

1.97

mmol/l

0.70

112

839

Hepatomegaly and splenomegaly, not elsewhere classified

5.05

2.07

1.4

1.2

2.06

1.86

mmol/l

—

Fracture of shoulder and upper arm

130

1013

1.28

2.07

1.3

2.20

2.04

mmol/l

0.82

124

939

Other coagulation defects

176

1.71

2.06

1.5

1.3

1.91

1.89

mmol/l

0.04

166

False labour

142

699

1.28

2.05

1.2

1.3

1.71

1.89

mmol/l

2.64

135

647

Other and unspecified primary disorders of muscles

4.07

2.05

1.0

1.3

1.90

1.66

mmol/l

—

Other local infections of skin and subcutaneous tissue

246

1.59

2.03

1.2

1.3

1.85

2.00

mmol/l

0.83

233

Melanoma in situ

2.12

2.03

1.0

1.2

1.98

2.04

mmol/l

0.14

Eosinophilia

3.11

2.02

1.5

1.3

1.93

1.83

mmol/l

—

Salpingitis and oophoritis

483

1.41

2.02

1.9

1.3

2.18

2.10

mmol/l

0.18

455

Other and unspecified local infections of skin and subcutaneous tissue

239

1.60

2.01

1.2

1.3

1.86

2.01

mmol/l

0.77

228

Vascular diseases of the intestine

2.23

2.01

1.2

1.1

2.46

2.04

mmol/l

0.94

Mature T/NK-cell lymphomas, hilmo

3.37

1.97

1.3

1.1

2.96

1.84

mmol/l

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

3.37

1.97

1.1

1.2

5.03

2.05

mmol/l

—

Other congenital malformations of brain

4.64

1.95

1.2

1.6

1.72

1.54

mmol/l

—

Hypertension, Pulmonary Arterial

4.60

1.95

1.4

2.16

1.75

mmol/l

—

Other arthrosis

198

1163

1.22

1.94

1.2

1.3

2.18

2.16

mmol/l

0.08

183

1078

Retinal vascular disorders

265

1.55

1.94

1.5

1.2

2.44

2.11

mmol/l

0.36

248

Endometriosis ASRM stages 1,2

549

1.37

1.89

1.1

1.3

1.80

1.97

mmol/l

0.77

513

Melanoma in situ of trunk

3.22

1.88

1.0

1.1

1.77

2.05

mmol/l

—

Melanoma in situ of trunk

3.22

1.88

1.0

1.2

1.77

1.80

mmol/l

—

Benign neoplasm: Other/unspecified site

2.88

1.87

1.3

1.2

1.95

2.12

mmol/l

—

Retinal vascular occlusion

260

1.54

1.86

1.5

1.2

2.47

2.11

mmol/l

0.38

244

Schizophrenia

475

1.39

1.84

1.2

1.3

2.02

1.98

mmol/l

0.16

443

Renal tubulo-interstitial disorders in diseases classified elsewhere

3.57

1.84

1.2

1.1

1.88

1.77

mmol/l

—

Recurrent dislocation of patella

137

1.76

1.83

1.1

1.5

2.22

1.83

mmol/l

0.37

130

Precocious central puberty

4.23

1.83

2.4

1.2

1.92

1.56

mmol/l

—

Intestinal stricture

104

803

1.30

1.83

1.3

2.01

2.14

mmol/l

0.78

754

Disorder of pancreatic internal secretion, other and/or unspecified

4.23

1.83

1.4

1.2

2.08

1.80

mmol/l

—

Lesion of femoral nerve

4.22

1.83

1.0

1.3

1.60

1.71

mmol/l

—

Other or ill-defined heart diseases

137

1.76

1.83

1.1

1.3

2.18

1.96

mmol/l

0.38

129

Transient synovitis

4.21

1.83

1.0

1.6

1.54

2.13

mmol/l

—

Pedal cyclist injured in other and unspecified transport accidents

310

1.49

1.82

1.4

1.3

1.84

1.99

mmol/l

0.86

288

Paralytic ileus and intestinal obstruction

647

1.33

1.82

1.3

1.92

2.13

mmol/l

2.18

601

Effects of foreign body entering through natural orifice

753

1.30

1.80

1.2

1.3

2.12

2.01

mmol/l

0.37

705

Perforation of tympanic membrane

264

1.52

1.76

1.2

1.3

2.03

2.02

mmol/l

0.01

247

Varus deformity, not elsewhere classified

3.37

1.75

1.5

1.4

2.37

1.97

mmol/l

—

Malignant neoplasm of heart, mediastinum and pleura

3.37

1.75

1.5

1.2

2.13

1.81

mmol/l

—

Benign lipomatous neoplasm

109

854

1.28

1.73

1.2

1.3

2.29

2.08

mmol/l

0.63

100

806

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2.95

1.73

1.6

1.2

2.29

1.81

mmol/l

—

Biological medication for rheuma

490

1.37

1.72

1.1

1.3

2.53

1.98

mmol/l

0.60

458

Drug-induced tremor

3.91

1.72

1.0

1.2

1.64

1.75

mmol/l

—

Migraine, unspecified, drug-induced

3.90

1.72

1.4

1.82

1.89

mmol/l

—

Parodontitis and operation codes

348

2361

1.15

1.72

1.3

2.14

2.13

mmol/l

0.05

323

2189

Coronary artery bypass grafting

577

0.71

1.72

1.2

2.46

2.20

mmol/l

0.52

542

Heart failure,strict

183

1093

1.21

1.70

1.3

2.22

2.20

mmol/l

0.07

172

1017

Spondylopathies (FG)

415

1.40

1.70

1.4

1.3

2.17

1.94

mmol/l

0.61

391

Wide developmental disorders, excluding more controls

2.21

1.70

1.3

1.2

1.42

1.75

mmol/l

1.34

Ulcerative colitis

760

1.29

1.70

1.3

1.92

1.99

mmol/l

0.40

712

Burn and corrosion of shoulder and upper limb, except wrist and hand

2.40

1.68

1.3

1.4

1.71

1.89

mmol/l

—

Lichen planus, including avohilmo

459

1.38

1.67

1.3

1.4

1.97

2.14

mmol/l

1.07

431

Other specified and unspecified strabismus

3.19

1.66

1.0

1.2

1.81

1.64

mmol/l

—

Respiratory disorders in diseases classified elsewhere

2.83

1.65

1.0

1.3

2.24

1.94

mmol/l

—

Follicular lymphoma, hilmo

1.90

1.65

1.1

1.2

2.01

1.99

mmol/l

0.05

Acute appendicitis, no complications

238

2026

1.17

1.65

1.2

1.3

1.83

2.04

mmol/l

4.16

221

1889

Injury of muscle and tendon at shoulder and upper arm level

124

996

1.25

1.62

1.2

1.3

2.15

2.17

mmol/l

0.07

116

927

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

163

920

1.22

1.61

1.2

1.3

2.27

2.20

mmol/l

0.22

146

854

Impacted teeth

590

1.31

1.61

1.6

1.3

1.87

1.75

mmol/l

0.52

552

Follicular lymphoma

1.88

1.60

1.1

1.2

2.01

1.97

mmol/l

0.08

Cardiodefibrillation

984

0.76

1.60

1.1

1.2

2.42

2.22

mmol/l

0.27

913

Other benign neoplasms of skin

132

1070

1.24

1.60

1.2

1.3

2.08

2.09

mmol/l

0.04

122

997

Non-ischemic cardiomyopathy

104

671

1.27

1.60

1.5

1.3

2.13

2.21

mmol/l

0.42

628

Diaphragmatic hernia

126

1019

1.24

1.56

1.3

2.11

2.13

mmol/l

0.06

113

950

Benign neoplasm of bone and articular cartilage

207

1.55

1.56

1.1

1.3

1.73

2.02

mmol/l

1.30

193

Chronic rhinitis, nasopharyngitis and pharyngitis

119

957

1.25

1.56

1.3

1.85

2.06

mmol/l

1.78

111

900

Appendectomy

276

2307

1.15

1.55

1.2

1.3

1.91

2.06

mmol/l

1.86

257

2143

Dental caries 2, only avohilmo

336

2328

1.14

1.55

1.3

1.2

1.92

2.00

mmol/l

0.71

313

2168

Other localized connective tissue disorders

2.44

1.54

1.6

1.3

2.34

2.06

mmol/l

—

Fracture of lower leg, including ankle

210

1780

1.18

1.53

1.1

1.3

2.14

2.10

mmol/l

0.18

198

1648

Hydrocele

273

1.47

1.53

1.2

2.08

2.09

mmol/l

0.03

255

Atopic dermatitis, strict definition

129

1028

1.23

1.53

1.2

1.3

1.84

1.85

mmol/l

0.05

124

963

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.38

1.53

2.0

1.2

2.60

1.90

mmol/l

—

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

3.36

1.53

1.0

1.3

2.06

2.14

mmol/l

—

Varicose veins

230

1487

1.17

1.52

1.3

2.21

2.20

mmol/l

0.02

214

1372

Acute myeloid leukaemia and myelodysplastic syndromes

2.61

1.52

1.6

1.2

3.33

1.86

mmol/l

—

Evidence of alcohol involvement determined by level of intoxication

2.88

1.51

1.2

1.3

3.63

1.90

mmol/l

—

Other disorders of choroid

2.88

1.51

1.3

1.2

3.00

1.93

mmol/l

—

Other specified/unspecified hearing loss

186

1.56

1.48

1.3

1.2

2.27

2.09

mmol/l

0.19

174

Family history of certain disabilities and chronic diseases leading to disablement

109

1.75

1.46

1.2

1.4

2.12

1.76

mmol/l

0.42

100

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

166

0.48

1.46

1.0

1.2

2.84

2.13

mmol/l

—

155

Lichen ruber planus, wide definition including periferal and oral lichen planus

540

1.32

1.46

1.3

1.4

1.97

2.13

mmol/l

1.08

508

Scleritis

2.52

1.45

1.1

1.3

1.75

1.88

mmol/l

—

Nail dystrophy

3.17

1.44

1.0

1.3

1.95

1.74

mmol/l

—

Malignant neoplasm of bone and articular cartilage

3.16

1.44

1.8

1.2

2.22

1.76

mmol/l

—

Other drug-induced secondary parkinsonism

3.16

1.44

1.4

1.1

2.47

1.89

mmol/l

—

Infections of genitourinary tract in pregnancy

277

1.45

1.44

1.5

1.2

2.01

1.96

mmol/l

0.16

257

Systemic sclerosis,strict definition

3.16

1.44

1.0

1.3

3.08

1.76

mmol/l

—

Acute mastoiditis

3.16

1.44

1.4

4.46

1.83

mmol/l

—

Drug-induced osteoporosis

2.75

1.44

1.0

1.3

1.95

1.90

mmol/l

—

Cauda equina syndrome

2.75

1.44

1.0

1.2

1.70

1.84

mmol/l

—

Non-allergic asthma (mode), excluding more controls

460

1.34

1.42

1.3

1.2

1.81

2.01

mmol/l

1.67

429

Dental caries 2

339

2358

1.13

1.42

1.4

1.2

1.93

2.00

mmol/l

0.68

316

2196

Endometriosis ASRM stages 3,4

701

1.27

1.42

1.1

1.3

2.07

2.01

mmol/l

0.12

651

Dental caries 2 and operation codes

333

2340

1.13

1.41

1.4

1.2

1.93

2.00

mmol/l

0.66

310

2180

Alzheimer’s disease (Late onset)

317

1.38

1.40

1.2

2.07

2.24

mmol/l

0.93

288

Examination and encounter for administrative purposes

1.86

1.40

1.1

2.32

1.95

mmol/l

0.60

Other and unspecified acne

2.43

1.39

1.3

1.1

2.03

1.63

mmol/l

—

Non-allergic asthma (mode)

462

1.33

1.39

1.3

1.2

1.81

2.01

mmol/l

1.63

430

Degenerative macular diseases

263

1.45

1.38

1.3

1.2

2.07

2.14

mmol/l

0.21

244

Glaucoma

187

1397

1.18

1.38

1.3

2.22

2.25

mmol/l

0.11

175

1291

Melanocytic naevi

105

847

1.24

1.37

1.1

1.3

2.07

1.96

mmol/l

0.23

793

Contact with venomous snakes and lizards

2.63

1.37

1.2

1.3

2.08

1.77

mmol/l

—

Malignant neoplasm of pancreas

121

0.41

1.37

1.0

1.2

3.00

2.05

mmol/l

—

112

Hypertrophy of (infrapatellar) fat pad

2.97

1.36

1.6

1.4

1.56

2.05

mmol/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

154

888

1.20

1.36

1.2

1.3

2.13

2.21

mmol/l

0.41

137

824

Benign neoplasm: Stomach

215

1.49

1.35

1.2

1.93

2.12

mmol/l

0.65

201

Hernia of abdominal wall

162

1368

1.19

1.34

1.3

2.04

2.11

mmol/l

0.28

151

1269

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

101

493

1.25

1.34

1.3

1.2

2.21

2.14

mmol/l

0.21

459

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

156

902

1.19

1.31

1.2

1.3

2.13

2.21

mmol/l

0.38

139

837

Preterm labour and delivery

100

808

1.24

1.30

1.3

1.99

2.02

mmol/l

0.12

750

Systemic sclerosis (FG)

2.10

1.30

1.0

1.3

2.51

2.05

mmol/l

—

Obstructed labour due to malposition and malpresentation of fetus

718

0.76

1.29

1.2

1.3

2.13

1.89

mmol/l

0.45

670

Helminthiases

2.37

1.29

1.3

1.96

1.79

mmol/l

—

Sulfasalazine

105

854

1.23

1.29

1.1

1.3

2.39

2.01

mmol/l

0.71

100

799

Other chondrocalcinosis

2.80

1.29

1.0

1.1

1.66

2.03

mmol/l

—

Gonarthrosis,primary

340

1904

1.12

1.28

1.3

2.10

2.21

mmol/l

1.25

304

1777

Anomalies of dental arch relationship, including avohilmo

558

1.27

1.28

1.4

1.3

1.77

1.91

mmol/l

1.00

516

Labour and delivery complicated by umbilical cord complications

133

0.45

1.28

2.0

1.4

1.55

1.97

mmol/l

—

124

Abnormal serum enzyme levels

102

818

1.23

1.27

1.3

1.2

2.26

2.18

mmol/l

0.23

764

Diseases of appendix

317

2571

1.12

1.27

1.2

1.3

1.90

2.08

mmol/l

2.40

292

2390

Embedded and impacted teeth

114

796

1.22

1.26

1.4

1.3

1.90

1.79

mmol/l

0.43

104

748

Early onset COPD

598

1.27

1.25

1.4

1.3

2.16

2.13

mmol/l

0.08

563

Coronary revascularization (ANGIO or CABG)

118

993

0.83

1.23

1.2

1.3

2.38

2.19

mmol/l

0.51

108

929

All-cause Heart Failure

189

1171

1.16

1.23

1.3

2.26

2.22

mmol/l

0.15

179

1088

Blepharochalasis

743

1.24

1.22

1.3

2.36

2.21

mmol/l

0.35

691

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

1.97

1.22

1.1

2.06

2.03

mmol/l

0.05

Appendicitis, broad definition

313

2553

1.12

1.22

1.2

1.3

1.90

2.08

mmol/l

2.36

288

2373

Benign neoplasm: Other parts of oropharynx

2.66

1.22

1.0

1.4

1.92

1.91

mmol/l

—

Other abnormal auditory perceptions

2.65

1.22

1.0

1.4

1.94

1.88

mmol/l

—

Benign neoplasm of bone and articular cartilage

221

1.45

1.21

1.1

1.3

1.73

2.02

mmol/l

1.35

207

Other and unspecified disorders of vitreous body

136

1138

1.19

1.21

1.2

1.3

2.01

2.24

mmol/l

2.37

127

1057

Disturbances of smell and taste

1.84

1.19

1.2

1.5

2.67

2.02

mmol/l

0.31

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

460

1.24

1.19

1.3

1.2

2.19

2.15

mmol/l

0.13

428

In situ neoplasms

116

919

1.21

1.18

1.2

1.3

1.98

2.10

mmol/l

0.57

109

851

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.71

1.17

1.2

1.5

1.75

mmol/l

0.00

Benign neoplasm of other and ill-defined parts of digestive system

419

1.32

1.17

1.1

1.4

2.16

2.09

mmol/l

0.16

396

Malignant neoplasm of skin

201

1314

1.15

1.17

1.2

1.3

2.17

2.26

mmol/l

0.62

180

1218

Ventral hernia

631

1.25

1.17

1.2

1.3

1.94

2.07

mmol/l

1.11

596

Benign neoplasm: Stomach

223

1.44

1.16

1.2

1.93

2.16

mmol/l

0.85

209

Burns classified according to extent of body surface involved

2.52

1.15

1.8

1.2

2.08

1.76

mmol/l

—

Chronic periodontitis, including avohilmo

358

2387

1.11

1.15

1.3

2.14

2.12

mmol/l

0.08

332

2207

Cellulitis of external ear

2.52

1.15

1.0

1.5

1.76

1.89

mmol/l

—

Heart failure, strict

191

1192

1.15

1.14

1.3

2.26

2.22

mmol/l

0.14

180

1108

Maternal care for other known or suspected fetal problems

109

577

1.21

1.14

1.1

1.2

1.90

1.79

mmol/l

0.31

102

536

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.86

1.13

1.3

1.5

1.53

2.12

mmol/l

1.67

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

2.01

1.12

1.5

1.3

2.20

1.89

mmol/l

—

Parodontitis or operation codes

359

2390

1.11

1.10

1.3

2.14

2.12

mmol/l

0.07

333

2210

Adenocarcinoma and papilloma adenocarcinoma of rectum

220

0.59

1.10

1.1

1.2

2.89

2.07

mmol/l

1.00

203

COPD (mode)

575

1.23

1.10

1.3

1.2

2.10

2.20

mmol/l

0.47

539

Benign neoplasm: Other parts of oropharynx

2.40

1.09

1.0

1.3

1.92

1.81

mmol/l

—

Degeneration of macula and posterior pole

140

984

1.17

1.07

1.3

2.12

2.26

mmol/l

0.99

129

905

Other disorders of veins

136

1159

1.17

1.06

1.2

1.3

2.07

2.10

mmol/l

0.09

128

1082

Cholangitis (primary sclerosing, PSC)

121

1.57

1.05

1.1

1.3

2.07

2.03

mmol/l

0.08

116

Non-rheumatic valve diseases

166

1048

1.16

1.05

1.4

1.3

2.26

2.12

mmol/l

0.60

151

977

Conduction disorders

102

705

1.20

1.04

1.2

1.3

2.23

2.11

mmol/l

0.53

663

Galactorrhea

2.29

1.03

1.0

1.4

1.97

1.86

mmol/l

—

Personal history of allergy to drugs, medicaments and biological substances

2.29

1.03

1.2

1.1

1.54

1.74

mmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

228

0.61

1.03

1.1

1.2

2.82

2.07

mmol/l

0.98

211

Shoulder region

2.29

1.03

1.0

1.1

1.48

1.81

mmol/l

—

Contracture of joint

2.29

1.03

1.6

1.2

1.54

1.97

mmol/l

—

Injury of nerves at forearm level

2.29

1.03

1.0

1.3

2.60

1.88

mmol/l

—

Placenta praevia

150

0.53

1.03

1.1

1.3

1.86

1.76

mmol/l

—

139

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

402

1.30

1.03

1.0

1.3

2.40

2.15

mmol/l

0.96

379

Glaucoma suspect

114

962

1.19

1.02

1.2

1.3

2.12

2.16

mmol/l

0.13

106

893

Systemic sclerosis

1.92

1.02

1.0

1.3

2.51

2.05

mmol/l

—

Parodontitis

357

2392

1.10

1.01

1.3

2.14

2.12

mmol/l

0.10

331

2212

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.65

1.00

1.3

1.2

2.71

1.99

mmol/l

0.78

Benign neoplasm: Skin of scalp and neck

1.88

1.00

1.2

2.19

1.98

mmol/l

—

Abnormal findings on examination of urine, without diagnosis

1.65

1.00

1.1

1.2

2.23

2.01

mmol/l

0.19

Pollen allergy

656

1.22

1.00

1.2

1.3

1.69

1.84

mmol/l

1.72

605

Injury of eye and orbit

395

1.29

1.00

1.2

1.3

1.78

1.98

mmol/l

2.40

374

Dermatitis due to ingested food

103

1.60

0.99

1.4

1.3

1.63

1.60

mmol/l

0.09

Abscess of lung

2.18

0.98

1.8

1.3

2.64

1.85

mmol/l

—

Valvular heart disease excluding rheumatic fever

167

1063

1.15

0.97

1.4

1.3

2.26

2.12

mmol/l

0.67

152

989

Ischemic heart diseases

297

1677

1.11

0.97

1.2

1.3

2.21

2.18

mmol/l

0.14

274

1562

malignant neoplasm of male genital organs

128

693

1.17

0.97

1.3

1.2

2.34

2.21

mmol/l

0.43

118

648

Acute appendicitis

290

2471

1.11

0.97

1.2

1.3

1.84

2.08

mmol/l

6.31

270

2298

Basal cell carcinoma

174

1213

1.14

0.97

1.2

1.3

2.11

2.27

mmol/l

1.06

155

1122

Impacted maxillary molar

165

1.46

0.96

1.2

1.4

1.80

1.76

mmol/l

0.14

151

Peritonsillar abscess

667

1.22

0.96

1.2

1.3

1.88

2.01

mmol/l

0.71

628

Systemic sclerosis, icd10

1.77

0.94

1.0

1.3

2.51

1.96

mmol/l

—

Combinations of oral blood glucose lowering drugs

769

1.20

0.94

1.3

2.48

2.11

mmol/l

2.16

726

386

1.28

0.93

1.3

1.2

2.09

2.23

mmol/l

0.68

351

Tumor necrosis factor alpha inhibitors

444

1.26

0.93

1.2

1.3

2.68

1.99

mmol/l

0.64

416

Artrosis, including avohilmo

366

1833

1.10

0.93

1.1

1.3

1.99

2.11

mmol/l

1.47

344

1706

Hypertrophy of breast

498

1.25

0.93

1.3

1.4

2.04

2.01

mmol/l

0.04

465

Benign neoplasm: Long bones of lower limb

1.72

0.92

1.1

1.3

1.71

1.86

mmol/l

0.45

Contraceptive management

174

1074

1.14

0.92

1.2

1.3

1.94

1.99

mmol/l

0.23

161

998

Hallux rigidus

330

1.31

0.92

1.2

1.4

2.92

2.02

mmol/l

0.62

308

Other inflammation of eyelid

339

1.30

0.92

1.2

1.77

2.05

mmol/l

2.11

318

Abscess of external ear

2.16

0.91

1.0

1.3

3.85

1.87

mmol/l

—

Contact with other hot metals

2.15

0.91

1.3

2.46

1.88

mmol/l

—

Dental caries 3 and operation codes, only avohilmo

148

644

1.16

0.90

1.5

1.3

1.93

2.04

mmol/l

0.84

142

599

Melanocytic naevi of trunk

314

1.31

0.89

1.1

1.2

2.15

1.96

mmol/l

0.31

291

Leiomyoma of uterus

178

882

1.14

0.89

1.3

2.11

2.03

mmol/l

0.33

167

818

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

2.08

0.89

1.2

1.3

1.60

1.82

mmol/l

—

Haemorrhoids and perianal venous thrombosis

782

1.19

0.89

1.3

2.16

2.17

mmol/l

0.02

726

Malignant neoplasm of ovary

103

0.48

0.89

1.0

1.2

1.71

2.22

mmol/l

—

Obesity, other/unspecified

125

1079

1.16

0.88

1.1

1.3

1.96

mmol/l

0.01

118

1018

Disorders of globe

1.91

0.88

1.1

1.2

2.70

1.87

mmol/l

—

Leiomyoma of uterus

234

1192

1.12

0.88

1.3

2.12

2.08

mmol/l

0.15

217

1097

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

2.01

0.87

2.3

1.1

3.14

2.04

mmol/l

—

Allergic contact dermatitis due to drugs in contact with skin

1.83

0.86

1.3

1.77

1.92

mmol/l

—

Heart failure and coronary heart disease

600

0.82

0.86

1.2

2.50

2.25

mmol/l

0.51

561

Other malignant neoplasms of skin (=non-melanoma skin cancer)

167

1165

1.13

0.84

1.2

1.3

2.16

2.26

mmol/l

0.58

149

1077

AV-block

393

1.25

0.83

1.1

1.2

2.18

2.08

mmol/l

0.39

370

Pre-eclampsia or eclampsia

689

1.19

0.82

1.3

2.26

1.96

mmol/l

0.85

646

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

1.58

0.81

1.2

1.3

1.74

1.78

mmol/l

0.14

Diseases of salivary glands

553

1.21

0.81

1.3

1.97

2.10

mmol/l

0.51

522

Coronary angioplasty

836

0.85

0.79

1.2

2.28

2.19

mmol/l

0.20

781

Certolizumab pegol

1.83

0.79

1.0

1.2

1.77

1.80

mmol/l

—

Laparoscopic left hemicolectomy

0.00

0.79

0.0

1.1

—

1.95

—

Myocardial infarction

138

1127

0.88

0.79

1.2

1.3

2.32

2.18

mmol/l

0.53

125

1055

Gonarthrosis, primary, with knee surgery

178

1297

1.12

0.78

1.3

2.14

2.26

mmol/l

0.78

154

1209

Malignant neoplasm of cervix uteri

0.00

0.78

0.0

1.3

—

1.96

—

COPD, hospital admissions 1, only main diagnosis

751

0.84

0.78

1.3

1.2

2.12

2.27

mmol/l

0.70

698

Acne

321

1.28

0.78

1.6

1.3

1.96

1.76

mmol/l

0.81

294

Malignant neoplasm of rectum

223

0.67

0.78

1.1

1.2

2.77

2.05

mmol/l

1.02

207

Clear cell adenocarcinoma of kidney

1.54

0.78

1.3

1.2

2.71

2.04

mmol/l

0.72

Malignant neoplasm of prostate

121

663

1.15

0.78

1.3

1.2

2.32

2.23

mmol/l

0.28

111

620

Other deformities of toe(s)

1.63

0.78

1.0

1.5

2.06

1.99

mmol/l

0.15

Malignant neoplasm of mesothelium and soft tissue

1.59

0.78

1.1

1.2

2.77

1.94

mmol/l

1.41

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.00

0.77

0.0

1.2

—

1.85

—

116

949

1.15

0.77

1.2

1.3

2.13

2.29

mmol/l

0.81

103

877

Emergency coronary revascularization (for ACS)

137

1118

0.88

0.77

1.2

2.35

2.19

mmol/l

0.49

126

1041

Asthma/COPD (KELA code 203)

404

2643

1.08

0.77

1.2

1.3

1.99

2.06

mmol/l

0.56

371

2455

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.00

0.76

0.0

1.3

—

1.84

—

Complications of labour and delivery

253

1282

1.10

0.76

1.3

1.99

2.01

mmol/l

0.09

237

1186

Fracture of femur

542

1.20

0.76

1.3

1.2

2.27

2.14

mmol/l

0.35

505

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

279

0.72

0.75

1.1

1.2

2.63

2.15

mmol/l

0.81

263

Hypertrophy of breast in women and men

577

1.20

0.75

1.4

1.3

2.06

2.02

mmol/l

0.08

537

Striae atrophicae

2.10

0.74

1.8

1.2

1.78

1.89

mmol/l

—

Contusion of toe(s) with damage to nail

2.10

0.74

1.0

1.2

1.88

1.77

mmol/l

—

Postmenopausal bleeding

416

1.18

0.73

1.6

1.2

2.16

2.20

mmol/l

0.12

383

Procreative management

128

949

1.14

0.73

1.2

1.3

1.92

mmol/l

0.03

117

877

Benign mammary dysplasia

361

1.25

0.72

1.4

2.06

2.19

mmol/l

0.54

340

Unspecified privation

272

1.29

0.72

2.1

1.3

1.97

2.04

mmol/l

0.15

256

Seropositive rheumatoid arthritis

688

1.18

0.72

1.1

1.3

2.25

2.12

mmol/l

0.47

644

Long labour

715

1.16

0.72

1.1

1.3

1.98

1.87

mmol/l

0.41

669

Other pulmonary heart/vessel disease

1.55

0.72

1.5

1.2

1.96

2.00

mmol/l

0.09

Basal cell carcinoma, including avohilmo

176

1244

1.11

0.71

1.2

1.3

2.12

2.28

mmol/l

1.16

157

1153

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

100

703

1.16

0.70

1.2

1.3

2.13

2.16

mmol/l

0.12

652

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

212

1894

1.10

0.70

1.3

1.92

2.01

mmol/l

0.79

193

1765

Event of undetermined intent

160

1.38

0.70

1.5

1.4

1.82

1.95

mmol/l

0.45

149

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

217

0.69

0.70

1.1

1.2

2.72

2.15

mmol/l

0.72

203

Complications predominantly related to the puerperium

842

1.15

0.69

1.2

1.3

2.00

1.94

mmol/l

0.14

786

Acne vulgaris

257

1.29

0.68

1.8

1.4

1.98

1.76

mmol/l

0.86

241

Benign neoplasm of other and ill-defined parts of digestive system

456

1.21

0.67

1.1

1.3

2.16

2.10

mmol/l

0.14

428

Primary gonarthrosis, bilateral

160

1257

1.11

0.67

1.3

2.23

2.25

mmol/l

0.08

143

1172

Premature rupture of membranes

585

1.16

0.67

1.2

1.81

1.87

mmol/l

0.23

545

Guttate psoriasis

1.79

0.66

1.4

1.3

3.36

1.89

mmol/l

—

In situ neoplasms

116

1025

1.13

0.65

1.2

1.3

1.98

2.08

mmol/l

0.46

109

944

Melanocytic naevi

105

922

1.14

0.65

1.1

1.3

2.07

1.99

mmol/l

0.15

867

Ischaemic heart disease, wide definition

286

1653

1.08

0.65

1.2

1.3

2.19

mmol/l

0.04

264

1540

Polypectomy (DHB20)

166

0.66

0.64

1.5

1.3

1.69

2.02

mmol/l

1.88

157

Ankylosing spondylitis, strict definition

127

0.63

0.64

1.6

1.5

2.90

1.88

mmol/l

—

120

Inflammation of lacrimal passages (acute and unspecified)

1.73

0.64

1.4

1.2

2.89

2.05

mmol/l

—

Melanocytic naevi of trunk

333

1.23

0.62

1.1

1.3

2.15

2.05

mmol/l

0.14

310

Major coronary heart disease event excluding revascularizations

186

1410

0.91

0.62

1.2

1.3

2.27

2.20

mmol/l

0.21

169

1311

HSIL lesion of the vagina

1.67

0.61

1.4

2.76

1.90

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

147

1.36

0.61

1.3

1.2

2.59

2.11

mmol/l

0.73

140

Anorexia

1.67

0.61

1.2

1.4

2.56

1.83

mmol/l

—

Carcinoma in situ of skin of scalp and neck

1.67

0.61

1.4

1.2

1.82

2.15

mmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

222

0.72

0.61

1.1

1.2

2.67

2.14

mmol/l

0.70

208

Fracture of forearm

194

1659

1.10

0.61

1.2

1.3

2.12

2.06

mmol/l

0.26

177

1540

Benign neoplasm: Sigmoid colon

408

1.20

0.59

1.2

1.4

2.09

2.16

mmol/l

0.14

381

Allergic conjunctivitis

222

2012

1.09

0.59

1.3

1.92

2.00

mmol/l

0.70

202

1876

Other noninflammatory disorders of uterus, except cervix

397

1.17

0.58

1.3

2.13

2.20

mmol/l

0.25

365

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

345

1.22

0.58

1.1

1.2

1.88

2.06

mmol/l

0.99

326

Impetigo

106

1.42

0.57

1.5

1.61

1.83

mmol/l

1.59

101

Unstable angina pectoris

883

0.88

0.57

1.2

2.24

2.23

mmol/l

0.01

824

Psoriasis vulgaris

549

1.17

0.56

1.2

1.3

1.86

2.04

mmol/l

1.50

516

Peroneal tendinitis

1.63

0.55

1.2

1.3

1.57

1.89

mmol/l

—

Speech therapy

774

0.86

0.55

1.1

1.3

2.13

2.08

mmol/l

0.15

729

Abrasion of teeth

102

665

1.13

0.55

1.4

1.3

2.09

2.07

mmol/l

0.06

618

Conductive hearing loss, unspecified

217

0.74

0.55

1.3

2.17

2.09

mmol/l

0.13

208

Alcohol-induced acute pancreatitis

1.47

0.54

1.0

1.4

1.97

2.02

mmol/l

0.13

Wide developmental disorders

1.45

0.52

1.3

1.42

1.76

mmol/l

1.99

Pure hyperglyceridaemia

1.50

0.51

1.5

1.2

1.83

1.86

mmol/l

—

Fall on and from ladder

179

1.29

0.51

1.0

1.2

2.03

2.04

mmol/l

0.03

167

Other appendicitis

224

1.25

0.50

1.1

1.3

2.52

2.06

mmol/l

0.35

211

Primary coxarthrosis, bilateral

725

1.13

0.50

1.2

1.3

2.11

2.19

mmol/l

0.40

675

Spermatocele

171

1.29

0.49

1.4

1.2

2.02

2.07

mmol/l

0.14

161

Foreign body on external eye

436

1.17

0.49

1.1

1.3

1.98

1.97

mmol/l

0.04

411

Rheumatic fever incl heart disease

1.56

0.49

1.3

2.01

1.94

mmol/l

—

Pre-eclampsia or poor fetal growth

114

1028

1.11

0.48

1.3

2.09

1.91

mmol/l

0.65

109

957

Polyp of the female genital tract

113

592

1.11

0.48

1.2

1.96

2.07

mmol/l

0.44

106

545

Benign neoplasm: Descending colon

147

1.29

0.45

1.1

1.2

2.10

2.09

mmol/l

0.01

137

L02BG Aromatase inhibitors

760

1.12

0.45

1.2

1.4

2.19

2.24

mmol/l

0.16

703

Umbilical hernia

790

1.11

0.44

1.3

2.13

2.04

mmol/l

0.22

741

Multiple delivery

238

1.22

0.44

1.4

1.3

2.19

1.91

mmol/l

0.49

219

Female infertility

118

663

1.10

0.43

1.3

1.2

1.81

1.98

mmol/l

1.88

112

615

Benign neoplasm: Descending colon

148

1.29

0.43

1.1

1.2

2.10

2.18

mmol/l

0.15

138

Left ventricular outflow tract obstruction, narrow definition

128

0.70

0.43

1.7

1.4

2.60

1.96

mmol/l

—

121

Normotensive glaucoma

166

1.27

0.43

1.4

1.2

1.86

2.17

mmol/l

1.33

154

Coxarthrosis, primary

184

1485

1.08

0.43

1.2

1.3

2.14

2.25

mmol/l

0.52

168

1375

Adhesive middle ear disease

1.62

0.43

1.0

1.2

2.48

1.79

mmol/l

—

Erosion of teeth, including avohilmo

636

1.12

0.43

1.4

1.3

1.96

mmol/l

0.01

594

Amputation of thigh

1.56

0.42

1.0

1.1

1.84

2.09

mmol/l

—

Congenital malformations of oesophagus

0.00

0.41

0.0

1.9

—

1.85

—

CR(E)ST syndrome

1.52

0.41

1.0

1.3

2.44

1.93

mmol/l

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.41

0.0

1.1

—

1.93

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.41

0.0

1.4

—

1.91

—

0.00

0.41

0.0

1.1

—

1.74

—

Other acquired deformities of ankle and foot

0.00

0.41

0.0

1.3

—

2.14

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

360

1.17

0.41

1.1

1.3

1.88

2.06

mmol/l

1.02

338

Crystalline deposits in vitreous body

0.00

0.41

0.0

1.1

—

1.81

—

Malignant neoplasm of breast, HER2-negative

155

1054

1.08

0.41

1.2

1.3

2.24

2.18

mmol/l

0.22

141

972

Benign neoplasm of breast

314

1.18

0.41

1.3

1.97

2.09

mmol/l

0.39

296

Benign neoplasm of breast

314

1.18

0.41

1.3

1.4

1.97

2.09

mmol/l

0.38

296

Carcinoma in situ of breast, lobular

0.00

0.41

0.0

1.2

—

1.96

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.41

0.0

1.4

—

1.90

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.40

0.0

1.5

—

1.86

—

Other interventions on the root canals of the tooth

1.47

0.40

1.8

1.2

2.14

1.75

mmol/l

—

Carcinoma in situ of skin of scalp and neck

1.47

0.40

1.4

1.0

1.82

2.12

mmol/l

—

Hypertrophic disorders of skin

141

1.28

0.40

1.5

1.3

1.75

1.88

mmol/l

0.39

134

Acquired stenosis of external ear canal

0.00

0.40

0.0

1.1

—

1.77

—

Exclusion endpoint for supernumerary teeth

0.00

0.40

0.0

1.3

—

1.93

—

Endometroid carcinoma of ovary

0.00

0.39

0.0

1.1

—

2.00

—

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.1

—

1.90

—

Malignant neoplasm of bladder

137

0.73

0.39

1.1

2.68

2.07

mmol/l

—

123

Other hammer toe(s) (acquired)

384

1.15

0.38

1.2

1.3

2.09

2.12

mmol/l

0.07

353

Skin changes due to chronic exposure to nonionizing radiation

103

891

1.09

0.38

1.2

1.3

2.14

2.31

mmol/l

0.75

823

Inflammatory disorders of breast

170

1.24

0.37

1.1

1.3

1.80

1.94

mmol/l

0.48

159

Abnormal findings in secretions and smears from cervix uteri vagina vulva

183

1347

1.07

0.37

1.4

1.3

2.08

1.99

mmol/l

0.32

177

1248

Gestational diabetes (for exclusion)

144

946

1.08

0.36

1.2

1.3

1.86

1.84

mmol/l

0.07

136

885

Unspecified jaundice

1.34

0.35

1.0

1.2

3.17

2.07

mmol/l

0.85

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

162

1.24

0.35

1.3

1.2

2.59

2.03

mmol/l

0.95

155

Myocardial infarction, without ST-elevation

109

926

1.09

0.35

1.2

2.29

2.25

mmol/l

0.16

865

Hypertrophic scar

126

1.27

0.35

1.5

1.4

1.78

1.89

mmol/l

0.31

120

Vascular disorders of the intestines

135

1.26

0.35

1.2

1.3

2.37

2.07

mmol/l

0.79

126

Sulfonylureas

725

1.09

0.34

1.1

1.2

2.53

2.15

mmol/l

1.52

671

Ectopic pregnancy

499

1.12

0.34

1.1

1.3

1.85

2.07

mmol/l

1.48

464

Left bundle-branch block

182

1.21

0.33

1.3

1.2

2.05

1.94

mmol/l

0.35

169

Malignant neoplasm of breast, HER-positive

900

1.09

0.32

1.2

1.3

2.14

2.22

mmol/l

0.39

832

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.28

0.32

1.0

1.2

2.23

1.93

mmol/l

—

Actinic keratosis

867

1.08

0.32

1.2

1.3

2.16

2.31

mmol/l

0.61

802

All dysplastic lesions of the cervix uteri, vagina or vulva

104

956

1.08

0.32

1.3

2.19

1.88

mmol/l

0.90

895

Malignant neoplasm of breast

158

1071

1.06

0.31

1.2

1.3

2.23

2.18

mmol/l

0.18

144

988

Peripheral artery disease

123

924

1.07

0.30

1.3

1.2

2.40

2.24

mmol/l

0.84

112

857

Laparoscopic right hemicolectomy

111

1.26

0.30

1.1

1.2

1.92

2.06

mmol/l

0.58

104

Single delivery by caesarean section

384

0.90

0.30

1.8

1.2

1.90

1.85

mmol/l

0.22

355

558

1.10

0.29

1.2

2.11

2.28

mmol/l

0.97

511

Carcinoma in situ, bladder

1.23

0.29

1.1

2.34

2.03

mmol/l

—

Benign neoplasm of other and unspecified female genital organs

110

0.73

0.29

1.1

1.2

2.08

2.17

mmol/l

—

105

Thyrotoxicosis with toxic multinodular goitre

130

1.23

0.28

1.4

1.2

2.48

2.15

mmol/l

0.44

124

Macular hole

111

0.72

0.28

1.0

1.1

1.76

2.09

mmol/l

—

103

COPD, hospital admission 2, with asthma infections

677

1.08

0.28

1.3

2.16

2.24

mmol/l

0.27

631

Sequelae of injuries of lower limb

259

0.85

0.28

1.0

1.4

1.88

2.02

mmol/l

0.59

245

COPD, hospital admissions 3, with asthma pneumonia sepsis

553

1.09

0.28

1.4

1.2

2.13

2.23

mmol/l

0.39

514

Pericarditis

1.30

0.28

1.1

1.3

1.74

1.86

mmol/l

0.55

Parodontitis or/and operation codes

272

1548

1.04

0.28

1.2

1.3

2.10

2.03

mmol/l

0.40

254

1432

Perineal laceration during delivery

522

0.90

0.28

1.1

1.2

1.73

1.78

mmol/l

0.20

492

Seropositive rheumatoid arthritis, wide

749

1.08

0.27

1.1

1.3

2.25

2.09

mmol/l

0.60

696

Other chronic obstructive pulmonary disease, including avohilmo

162

1276

1.06

0.27

1.3

2.17

2.21

mmol/l

0.13

147

1182

COPD, early/later onset

119

1069

0.94

0.26

1.3

2.16

2.24

mmol/l

0.41

109

994

Injury of muscle and tendon at hip and thigh level

253

1.15

0.26

1.3

1.85

2.04

mmol/l

0.78

238

Inguinal hernia

217

1399

1.05

0.25

1.2

1.3

2.12

mmol/l

0.03

203

1305

Embolic stroke

1.22

0.25

1.0

1.1

2.34

2.07

mmol/l

—

Crossbite

175

1.17

0.24

1.2

1.4

1.50

1.79

mmol/l

3.44

164

Other/unspecified seropositive rheumatoid arthritis

735

1.08

0.24

1.1

1.3

2.25

2.10

mmol/l

0.61

683

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

147

0.82

0.23

1.0

1.2

2.02

2.12

mmol/l

0.16

139

Angina pectoris

182

1286

0.96

0.23

1.2

1.3

2.18

2.21

mmol/l

0.14

167

1197

COPD, hospital admissions

118

1056

0.95

0.23

1.3

2.14

2.24

mmol/l

0.59

108

983

Other specified/unspecified deforming dorsopathies

1.28

0.23

2.0

1.2

2.04

2.00

mmol/l

—

Polycystic ovarian syndrome

162

1.17

0.23

1.2

1.4

1.61

1.74

mmol/l

0.72

150

Oesophageal varices

0.76

0.22

1.6

1.3

2.33

2.04

mmol/l

—

Major coronary heart disease event

220

1527

0.96

0.22

1.2

1.3

2.24

2.20

mmol/l

0.15

202

1420

Foreign body or object entering through skin

172

1.16

0.22

1.3

1.4

1.72

2.00

mmol/l

1.86

163

Postmenopausal atrophic vaginitis

426

1.07

0.21

1.2

1.3

1.99

2.19

mmol/l

1.10

393

Benign neoplasm: Female genital organ, unspecified

0.00

0.21

0.0

1.4

—

2.03

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

1.2

—

1.60

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.2

—

1.89

—

Down's syndrome

0.00

0.21

0.0

2.0

—

1.68

—

Other specified and unspecified disorders of iris and ciliary body

0.00

0.21

0.0

1.2

—

1.80

—

Other congenital malformations of kidney

0.00

0.21

0.0

1.3

—

1.66

—

Hypospadias

0.00

0.21

0.0

1.2

—

1.77

—

Chronic thyroiditis

0.00

0.21

0.0

1.5

—

2.14

—

Carcinoma in situ of vagina

0.00

0.21

0.0

1.4

—

2.00

—

Carcinoma in situ of vagina

0.00

0.21

0.0

1.4

—

1.97

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.4

—

1.94

—

Adenocarcinomas of cervix

0.00

0.21

0.0

1.4

—

2.08

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.1

—

1.85

—

Surgical ablation of atrial fibrillation

0.00

0.21

0.0

1.4

—

1.79

—

Familial erythrocytosis

0.00

0.21

0.0

1.2

—

1.69

—

Other specified/unspecified diseases of inner ear

0.00

0.21

0.0

1.2

—

1.78

—

Abnormality of red blood cells

0.00

0.21

0.0

1.2

—

1.73

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.21

0.0

1.3

—

1.65

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.2

—

1.75

—

Felty syndrome

0.00

0.21

0.0

1.2

—

2.06

—

Other benign neoplasm of uterus: Cervix uteri

0.00

0.21

0.0

1.3

—

1.84

—

Other benign neoplasm of uterus: Cervix uteri

0.00

0.21

0.0

1.2

—

1.86

—

Birth trauma

0.00

0.21

0.0

2.1

—

1.70

—

Squamous cell neoplasms and carcinoma of cervix

0.00

0.21

0.0

1.4

—

1.99

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.21

0.0

1.1

—

1.72

—

Gangrene, not elsewhere classified

0.00

0.21

0.0

1.1

—

1.91

—

Prophylactic surgery

0.00

0.21

0.0

1.3

—

1.86

—

Benign neoplasm: Endocrine pancreas

0.00

0.21

0.0

1.3

—

1.75

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

0.21

0.0

1.5

—

1.76

—

Deformity of finger(s)

0.00

0.21

0.0

1.2

—

1.98

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.21

0.0

1.1

—

1.79

—

Lymphangioma, anys site

0.00

0.21

0.0

1.8

—

1.80

—

Lymphangioma, anys site

0.00

0.21

0.0

1.7

—

1.78

—

Carcinoma in situ of skin

154

1.17

0.21

1.1

1.2

1.85

2.14

mmol/l

1.77

145

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.2

—

1.80

—

Benign neoplasm: Endocrine pancreas

0.00

0.21

0.0

1.2

—

1.77

—

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.4

—

2.01

—

Injury of blood vessels at wrist and hand level

0.00

0.21

0.0

1.1

—

1.72

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.21

0.0

1.3

—

1.89

—

Scarlet fever

0.00

0.21

0.0

1.3

—

1.69

—

Erectile dysfunction

192

1.15

0.20

1.3

1.2

2.16

2.05

mmol/l

0.39

177

Right side

0.00

0.20

0.0

1.1

—

1.89

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.20

0.0

1.1

—

1.98

—

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.4

—

1.93

—

Carcinoma in situ of breast, lobular

0.00

0.20

0.0

1.0

—

1.96

—

Bullous keratopathy

0.00

0.20

0.0

1.1

—

1.94

—

Villonodular synovitis (pigmented)

0.00

0.20

0.0

1.4

—

1.96

—

Xanthelasma of eyelid

0.00

0.20

0.0

1.2

—

1.79

—

Caries in Clefts patients

0.00

0.20

0.0

1.4

—

1.88

—

Coronary atherosclerosis

232

1443

1.04

0.20

1.2

1.3

2.19

2.21

mmol/l

0.09

216

1344

Benign neoplasm: Sigmoid colon

452

1.08

0.19

1.2

2.09

2.16

mmol/l

0.15

422

Single spontaneous delivery

133

742

0.95

0.19

1.2

2.12

2.02

mmol/l

0.33

126

680

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

128

1.17

0.18

1.3

1.4

2.34

2.16

mmol/l

0.13

120

L02BX Other hormone antagonists and related agents

121

0.83

0.18

1.0

1.1

2.96

2.05

mmol/l

—

109

Carcinoma in situ of other and unspecified sites

1.15

0.17

1.1

2.34

2.03

mmol/l

—

Malignant neoplasm of breast, HER-negative

522

1.07

0.17

1.2

1.4

2.42

2.14

mmol/l

0.56

485

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

139

870

1.04

0.17

1.2

1.3

2.26

2.13

mmol/l

0.56

126

806

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

139

870

1.04

0.17

1.2

1.3

2.26

2.13

mmol/l

0.56

126

806

Carcinoma in situ of skin

157

1.15

0.17

1.1

1.2

1.85

2.08

mmol/l

1.46

145

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

728

1.06

0.17

1.1

1.3

2.27

2.10

mmol/l

0.64

676

Malignant neoplasm of oral cavity

0.71

0.16

1.2

1.59

2.03

mmol/l

—

Rubella [German measles]

1.21

0.15

1.2

1.4

1.90

2.02

mmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

1.15

0.15

1.3

1.1

2.28

2.03

mmol/l

—

1.12

0.15

1.4

1.3

1.48

1.51

mmol/l

—

Use of ropinirole

1.08

0.14

1.1

1.2

2.00

1.96

mmol/l

—

Dental caries 2 and operation codes, only avohilmo

302

1829

1.02

0.14

1.4

1.2

1.95

2.00

mmol/l

0.33

281

1697

Maternal care for known or suspected abnormality of pelvic organs

607

0.95

0.14

1.2

1.80

1.91

mmol/l

0.92

564

Congenital malformations of aortic and mitral valves

100

0.80

0.13

1.8

1.2

2.71

1.97

mmol/l

—

Coxarthrosis, primary, with hip surgery

129

1180

1.04

0.13

1.2

1.3

2.20

2.27

mmol/l

0.21

121

1088

Labour and delivery complicated by fetal stress [distress]

607

0.96

0.13

1.3

1.2

1.81

1.77

mmol/l

0.25

569

Pregnancy hypertension

150

1309

1.03

0.13

1.3

2.21

1.97

mmol/l

1.04

139

1221

Presence of cardiac and vascular implants and grafts

123

898

1.04

0.13

1.1

1.3

2.30

2.25

mmol/l

0.16

110

836

Ulcerative ileocolitis

106

0.85

0.13

1.1

1.5

2.07

1.90

mmol/l

—

Oesophagitis

123

1.14

0.12

1.2

1.3

1.94

2.09

mmol/l

0.36

115

Delivery

137

749

0.97

0.12

1.5

1.2

2.18

2.01

mmol/l

0.58

129

687

Delivery, wide proxy

114

629

0.96

0.12

1.5

1.2

2.06

1.98

mmol/l

0.41

107

572

L02BB Anti-androgens

179

0.89

0.12

1.6

1.2

2.55

2.14

mmol/l

0.67

163

Medicines for HER+ breast cancer

101

948

1.04

0.12

1.2

1.3

2.13

2.20

mmol/l

0.34

874

Other diseases of biliary tract

191

1.10

0.11

1.0

1.3

2.33

2.11

mmol/l

0.40

181

Gestational [pregnancy-induced] hypertension

872

0.96

0.11

1.2

1.3

2.00

1.91

mmol/l

0.23

821

COPD related to multimorbidity

106

862

1.04

0.11

1.3

1.2

2.21

2.25

mmol/l

0.16

800

Exclusion endpoint for clefts

1.11

0.10

1.2

1.3

1.58

1.77

mmol/l

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

571

1.04

0.09

1.2

1.4

2.38

2.18

mmol/l

0.40

531

Other chronic obstructive pulmonary disease

119

1017

0.97

0.09

1.3

2.16

2.22

mmol/l

0.28

109

948

Malignant neoplasm of thyroid gland

165

0.91

0.08

1.1

1.4

1.90

2.04

mmol/l

0.61

156

Calcific aortic valvular stenosis, operated

640

0.96

0.08

1.2

2.54

2.25

mmol/l

0.53

589

Calcific aortic valvular stenosis

640

0.96

0.08

1.2

2.54

2.25

mmol/l

0.53

589

Operations 2 for CAVS

639

0.96

0.08

1.2

2.54

2.25

mmol/l

0.53

588

Calcific aortic valvular stenosis, diagnosis (helper)

639

0.96

0.08

1.2

2.54

2.25

mmol/l

0.53

588

Other specified disorders of kidney and ureter

1.03

0.08

1.1

1.2

2.55

2.01

mmol/l

—

Dronedarone medication

0.83

0.07

1.2

2.37

1.84

mmol/l

—

Other specified disorders of external ear

1.03

0.07

1.9

1.2

1.81

2.02

mmol/l

—

Lesion of sciatic nerve

0.85

0.07

1.6

1.1

1.85

2.04

mmol/l

—

Persons encountering health services in circumstances related to reproduction

215

1480

0.98

0.07

1.4

1.3

1.95

2.00

mmol/l

0.29

202

1369

Medical treatment for female infertility

734

0.98

0.04

1.3

1.2

1.79

1.86

mmol/l

0.41

687

Calcific aortic valvular stenosis, including rheumatic fever

640

0.98

0.04

1.2

2.52

2.25

mmol/l

0.51

589

Malignant neoplasm of endocrine gland

180

0.94

0.04

1.1

1.4

1.97

2.08

mmol/l

0.36

171

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

163

1409

1.01

0.04

1.2

1.3

2.18

1.98

mmol/l

0.83

151

1312

COPD

126

1053

0.99

0.03

1.3

2.15

2.21

mmol/l

0.27

115

982

Carbimazole or st.post thyroidectomy, condition for graves disease

587

1.02

0.03

1.3

2.00

mmol/l

0.01

552

Other orthopaedic follow-up care

122

1.07

0.02

1.2

1.92

2.14

mmol/l

0.48

117

Other and unspecified glaucoma

132

1.06

0.02

1.5

1.2

2.24

2.09

mmol/l

0.20

123

Heart failure and bmi 25plus

676

0.99

0.02

1.2

1.3

2.23

2.29

mmol/l

0.15

630

Diabetes mellitus in pregnancy

119

778

0.99

0.01

1.2

1.85

1.84

mmol/l

0.02

113

724

Atherosclerosis, excluding cerebral and coronary sclerosis

106

841

1.01

0.01

1.3

1.2

2.41

2.25

mmol/l

0.72

776

Cardiomyopathy, other and unspecified

214

1.03

0.00

1.1

1.3

2.36

1.99

mmol/l

0.52

203

Embedded teeth, including avohilmo

294

1.02

0.00

1.2

1.3

2.00

1.81

mmol/l

0.21

275

Carcinoma in situ of skin of other and unspecified parts of face

145

0.97

0.00

1.3

1.1

1.96

2.06

mmol/l

0.26

133

Carcinoma in situ of skin of other and unspecified parts of face

139

1.01

0.00

1.3

1.1

1.96

2.21

mmol/l

0.85

130

Other and/or unspecified nontoxic goitre

181

0.99

0.00

1.3

1.4

2.03

2.19

mmol/l

0.28

171

Injury of muscle and tendon at lower leg level

415

0.99

0.00

1.2

1.3

2.13

2.05

mmol/l

0.24

390

Biomechanical lesions, not elsewhere classified

114

0.96

0.00

1.2

1.4

1.77

2.03

mmol/l

2.03

107

Ulcer of oesophagus

164

0.98

0.00

1.1

1.2

2.17

2.09

mmol/l

0.23

154

Pacemaker

768

1.00

0.00

1.2

2.05

2.25

mmol/l

1.34

710

Tooth eruption problems

471

1.01

0.00

1.1

1.3

1.85

1.74

mmol/l

0.20

438

Adjustment and management of implanted device

391

1.00

0.00

1.1

1.2

1.93

2.18

mmol/l

1.15

366

Other menopausal disorders

491

1.00

0.00

1.2

1.3

1.94

2.14

mmol/l

1.05

450

Other osteochondropathies

197

1.02

0.00

1.4

2.00

1.98

mmol/l

0.05

185

Maternal care related to the fetus and amniotic cavity and possible delivery problems

165

968

1.00

0.00

1.2

1.3

1.85

1.95

mmol/l

0.66

160

891

Effects of air pressure and water pressure

0.00

0.0

1.7

—

1.62

—

Operations 1 for CAVS

0.00

0.0

1.2

—

1.70

—

Benign neoplasm: Rectosigmoid junction

1.01

0.00

1.1

1.2

1.76

2.02

mmol/l

—

Benign neoplasm: Hypopharynx

0.00

0.0

1.1

—

1.67

—

Benign neoplasm: Mediastinum

0.00

0.0

1.0

—

1.65

—

Cleft lip

0.00

0.0

1.6

—

1.60

—

Carcinoma in situ of oral cavity, oesophagus and stomach

0.00

0.0

1.1

—

1.95

—

Hereditary factor VIII deficiency

0.00

0.0

1.1

—

1.53

—

Benign neoplasm: Hypopharynx

0.00

0.0

1.2

—

1.71

—

Benign neoplasm: Scrotum

0.00

0.0

1.3

—

1.60

—

Chronic respiratory disease originating in the perinatal period

0.00

0.0

1.8

—

1.43

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

0.0

1.1

—

2.05

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.6

—

2.01

—

Crushing injury of forearm

0.00

0.0

1.7

—

2.08

—

Wilms' tumor, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

1.71

—

Other rupture of muscle

0.00

0.0

1.5

—

2.49

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

0.0

1.2

—

1.79

—

Generalized pustular psoriasis

0.00

0.0

1.4

—

2.22

—

Lipomatosis, not elsewhere classified

0.00

0.0

1.7

—

1.73

—

Injury of blood vessels at shoulder and upper arm level

0.00

0.0

1.0

—

1.89

—

Drug-induced gout

0.00

0.0

1.0

—

1.97

—

Cleft lip and cleft lip and palate

0.00

0.0

1.3

—

1.65

—

Need for immunization against single bacterial diseases

0.00

0.0

2.3

—

1.43

—

Sickle-cell disorders

0.00

0.0

1.4

—

1.60

—

Other sideroblastic anaemias

0.00

0.0

1.0

—

1.66

—

Burn and corrosion of other internal organs

0.00

0.0

1.2

—

1.81

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

1.67

—

Burn and corrosion, body region unspecified

0.00

0.0

1.4

—

1.77

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

0.0

1.4

—

1.63

—

Chondrosarcoma

0.00

0.0

1.0

—

2.05

—

Other and unspecified parapsoriasis

0.00

0.0

1.3

—

1.77

—

Benign neoplasm: Testis

0.00

0.0

1.3

—

1.89

—

Biliary cirrhosis, NAS

0.00

0.0

1.2

—

1.87

—

Carcinoma in situ of other and unspecified sites

0.97

0.00

1.1

2.34

2.06

mmol/l

—

General- and plastic-surgery devices associated with adverse incidents

0.00

0.0

1.8

—

2.18

—

Carcinoma in situ of oral cavity

0.00

0.0

1.2

—

1.70

—

Bicuspidal aortic valve syndrome

0.90

0.00

1.7

1.2

2.71

2.03

mmol/l

—

Carcinoma in situ, bladder

1.00

0.00

1.1

2.34

2.03

mmol/l

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.2

—

1.76

—

Hypertrophy of bone

0.00

0.0

1.5

—

1.67

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.4

—

1.42

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.0

1.2

—

1.75

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.0

1.0

—

1.95

—

Benign neoplasm: Scrotum

0.00

0.0

1.3

—

1.70

—

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

1.65

—

Lordosis

0.00

0.0

1.5

—

1.72

—

Femoral hernia

0.95

0.00

1.2

2.69

2.04

mmol/l

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.0

1.2

—

1.55

—

Wilms' tumor

0.00

0.0

1.3

—

1.66

—

Fitting and adjustment of external prosthetic device

0.00

0.0

1.4

—

1.89

—

Frostbite with tissue necrosis

0.00

0.0

1.6

—

1.81

—

Cleft lip and palate

0.00

0.0

1.3

—

1.65

—

Erectile dysfunction, exclusion

0.00

0.0

1.3

—

1.77

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

2.00

—

Paget disease

0.00

0.0

1.0

—

1.81

—

Polycythaemia vera

0.87

0.00

1.5

1.2

2.10

2.03

mmol/l

—

Benign neoplasm: Lymph nodes

0.00

0.0

1.4

—

1.70

—

Granulosa cell carcinoma of ovary

0.00

0.0

1.4

—

1.88

—

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

1.68

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.0

1.4

—

1.96

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.0

1.2

—

1.78

—

Mucinous and mucinous cystic tumor

0.00

0.0

1.2

—

1.97

—

Benign neoplasm: Lymph nodes

0.00

0.0

1.4

—

1.67

—

Ototoxic hearing loss

0.00

0.0

1.0

—

1.76

—

Disorders of glossopharyngeal nerve

0.00

0.0

1.0

—

1.90

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.0

1.0

—

1.72

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.00

0.0

1.7

—

2.01

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.0

1.0

—

1.72

—

Urethral discharge

0.00

0.0

1.4

—

1.81

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.0

1.4

—

1.74

—

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

1.88

—

Pneumoconiosis due to dust containing silica

0.00

0.0

1.2

—

1.69

—

Complications specific to multiple gestation

0.00

0.0

1.3

—

1.70

—

Phantom limb syndrome

0.00

0.0

1.2

—

1.73

—

Family history of mental and behavioural disorders

0.00

0.0

1.0

—

1.52

—

Changes in corneal membranes

0.00

0.0

1.0

—

1.55

—

Benign neoplasm: Mediastinum

0.00

0.0

1.0

—

1.73

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

0.0

1.2

—

1.65

—

Maxillary hypoplasia

0.00

0.0

1.4

—

1.49

—

Non-neuropathic heredofamilial amyloidosis

0.00

0.0

1.0

—

1.63

—

Benign neoplasm: Testis

0.00

0.0

1.3

—

1.82

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.3

—

1.74

—

Other congenital malformations of eye

0.00

0.0

1.8

—

1.47

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.0

1.2

—

1.78

—

Corneal pigmentations and deposits

0.00

0.0

1.4

—

1.76

—

Carcinoma in situ of endometrium

0.00

0.0

1.1

—

1.78

—

Isolated patent ductus arteriosus

0.00

0.0

1.4

—

2.11

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.0

1.8

—

1.36

—

Thyroid crisis or storm

0.00

0.0

1.8

—

1.99

—

Malignant neoplasm of gum

0.00

0.0

1.0

—

1.96

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.0

1.0

—

1.61

—

0.00

0.0

1.0

—

1.23

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.0

1.0

—

1.14

—

Carcinoma in situ of oral cavity

0.00

0.0

1.2

—

1.66

—

ILD medications: acetylcysteine

0.00

0.0

1.1

—

2.14

—

Eccrine sweat disorders

0.00

0.0

1.6

—

1.80

—

Chorioretinal scars

0.00

0.0

1.1

—

1.83

—

Congenital malformations of lung

0.00

0.0

1.8

—

1.52

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

0.0

1.0

—

1.95

—

Cleft hard palate NOS

0.00

0.0

1.8

—

2.02

—

Liver disorders in diseases classified elsewhere

0.00

0.0

1.2

—

1.63

—

Epidermolysis bullosa

0.00

0.0

1.4

—

1.44

—

Foreign object accidentally left in body during surgical and medical care

0.00

0.0

1.4

—

1.70

—

Congenital malformation of biliary tract

0.00

0.0

1.7

—

1.45

—

Myasthenia gravis, drug-induced

0.00

0.0

1.0

—

1.73

—

Other operation for atrial fibrillation

0.00

0.0

1.1

—

1.71

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.2

—

1.72

—

Ulcer of oesophagus, drug-induced

0.00

0.0

1.1

—

1.95

—

Interstitial cystitis (chronic), drug-induced

0.00

0.0

1.4

—

1.72

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.0

1.4

—

1.68

—

Maze procedure for atrial fibrillation

0.00

0.0

1.3

—

1.91

—

Diphtheria

0.00

0.0

1.3

—

1.66

—

Other disturbances of cerebral status of newborn

0.00

0.0

2.2

—

1.35

—

Other or unspecified immunodeficiency

0.00

0.0

1.3

—

1.94

—

Other haemoglobinopathies

0.00

-0.00

0.0

1.4

—

1.70

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate [Moles/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS